Kevin J Boran, MD
Interventional Cardiology · Fresno
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 4
- Since medical school
- 49 years
- University of Pittsburgh School of Medicine, 1977
Offices
4 locations · Cardiovascular Consultants of Fresno, A Professional Corporation · Saint Agnes Medical Center · Fresno Community Hospital and Medical Center
Hospitals listed: Clovis Community Medical Center · Community Regional Medical Center · Saint Agnes Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Boran’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence G56843 · Current
Licensed to practise in California · since 1986 · expires 2027-09-30 · University of Pittsburgh School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Clovis Community Medical CenterClovis, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Community Medical Centers, which runs 4 hospitalsPatients rate it 3 of 5 · 80% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.7 (12.1 to 17.7) · 421 cases, Jan 2024 – Dec 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.692, Oct 2024 – Sep 2025
- Community Regional Medical CenterFresno, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Community Medical Centers, which runs 4 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 1 of 5 starsWorse than the national rate — Death rate among surgical inpatients with serious treatable complications: 211.21 (174.88 to 247.54) · 239 cases, Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.705, Oct 2024 – Sep 2025
- Saint Agnes Medical CenterFresno, CAAcute Care Hospital · Voluntary non-profit - Church · Has an emergency department · Birthing-friendlyPart of Trinity Health, which runs 105 hospitals in 16 statesPatients rate it 3 of 5 · 76% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.274, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.312, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.141, Oct 2024 – Sep 2025
See every measure and the patient survey for Clovis Community Medical Center
Behind the star rating — Deaths: 1 better, 7 the same, 0 worse of 8 measures. Safety: 0 better, 6 the same, 1 worse of 7 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.7 (12.1 to 17.7) · 421 cases | Worse | Jan 2024 – Dec 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.692 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.97 (0.04 to 1.89) · 1,840 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.16 (0.86 to 1.45) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 217.06 (167.45 to 266.67) · 84 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.4 · 69 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 9.1 · 165 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 13.4 · 161 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 14 · 507 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17.6 · 798 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 336 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 3,771 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.39) · 8,649 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.08 to 0.46) · 9,146 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.46 (1.47 to 5.45) · 1,654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.19 (0.61 to 3.78) · 387 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.18 (0.7 to 3.66) · 1,578 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 13.47 (7.08 to 19.87) · 374 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.99 (1.37 to 8.61) · 379 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.58 (0.13 to 3.04) · 405 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.8 (0.23 to 1.38) · 8,198 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.2 · 90 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.651 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.922 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.449 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.509 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.3 · 210 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 23 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -1.5 · 152 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 58.4 · 556 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18 · 769 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.8 · 802 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.5 (4 to 7.4) · 421 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.2 · 91 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 93 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 200 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.8 to 15.6) · 2,398 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1.1) · 720 cases | No different | Jan 2024 – Dec 2024 |
What patients said (441 patients answered, 26% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 80% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 69% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 72% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 52% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 48% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for Community Regional Medical Center
Behind the star rating — Deaths: 0 better, 7 the same, 1 worse of 8 measures. Safety: 0 better, 7 the same, 0 worse of 7 measures. Readmissions: 0 better, 7 the same, 3 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 211.21 (174.88 to 247.54) · 239 cases | Worse | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.705 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.13 (0.29 to 1.96) · 2,304 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.09 (0.87 to 1.3) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 3.2 · 187 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 116 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.7 · 187 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.6 · 445 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.2 · 399 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 582 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 3,744 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.31 (0.12 to 0.5) · 11,052 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,566 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.33 (1.64 to 5.01) · 3,139 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.08 (0 to 2.3) · 1,423 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.7 (0.52 to 2.88) · 3,084 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.85 (8.11 to 15.6) · 1,481 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.4 (3.81 to 8.98) · 1,404 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.35 (0.95 to 3.76) · 760 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.64 (0.16 to 1.11) · 10,254 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.817 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.031 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.837 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.81 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.853 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 258 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 689 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 37.4 · 202 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 35.2 · 543 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 39.2 · 434 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19.3 · 552 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.4 (3.6 to 7.9) · 169 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.4 (8.3 to 15.4) · 169 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 12.4 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.6 · 248 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 11.9 (9.5 to 14.9) · 2,590 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 310 cases | No different | Jan 2024 – Dec 2024 |
What patients said (421 patients answered, 26% of those asked)
| Cleanliness | 4 |
| Nurse communication | 2 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 74% |
| Nurses "always" communicated well | 74% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 55% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 66% |
| Staff "always" explained new medications | 69% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 70% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 41% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for Saint Agnes Medical Center
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 2 better, 6 the same, 0 worse of 8 measures. Readmissions: 0 better, 6 the same, 3 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.274 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.312 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.141 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.18 to 1.94) · 2,342 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.27) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 197.82 (152.64 to 243.01) · 103 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 3.9 · 105 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.3 · 300 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.9 · 295 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.8 · 768 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.8 · 969 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.2 · 304 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 4,305 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.06 to 0.42) · 11,641 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.07 to 0.43) · 12,213 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.76 (2.91 to 6.61) · 2,466 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.09 (0 to 2.49) · 864 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.61 (0.26 to 2.96) · 2,362 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.1 (5.39 to 14.81) · 900 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.4 (1.2 to 7.59) · 882 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.84 (0.41 to 3.27) · 541 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.67 (0.14 to 1.19) · 9,626 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.9 · 58 cases | None | Apr 2023 – Mar 2025 |
| MRSA BacteremiaInfections | 0.835 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 1.182 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.004 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 412 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.6 · 1,002 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 28.8 · 296 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 25.5 · 894 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 17.8 · 981 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 1,061 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5 · 56 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 13.4 · 150 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 412 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.3 (9.6 to 15.9) · 1,324 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.1) · 863 cases | No different | Jan 2024 – Dec 2024 |
What patients said (812 patients answered, 32% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 74% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 71% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 70% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 50% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
Original Medicare doctor bills
$2,081,036
Medicare paid this office $2,081,036 for 3,190 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | 321 | $506,705 | $1,535 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 321 | $268,480 | $407 |
| Return visit (30+ min) | 1,511 | $256,652 | $96 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 698 | $247,343 | $354 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 926 | $142,485 | $151 |
See all 61 services
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | 321 | $506,705 | $1,535 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 321 | $268,480 | $407 |
| Return visit (30+ min) | 1,511 | $256,652 | $96 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 698 | $247,343 | $354 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 926 | $142,485 | $151 |
| Long return visit (40+ min) | 310 | $67,314 | $139 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 1,128 | $59,765 | $51 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 697 | $57,361 | $41 |
| Insertion of heart rhythm monitor under skin | 13 | $45,907 | $3,531 |
| Nuclear medicine study of heart muscle blood flow by pet | 321 | $36,429 | $110 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 59 | $29,592 | $71 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 173 | $24,882 | $134 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 126 | $21,408 | $170 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 39 | $20,737 | $399 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 117 | $17,780 | $91 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 94 | $16,432 | $171 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 42 | $15,787 | $47 |
| Programming of dual lead pacemaker system | 133 | $15,477 | $60 |
| New patient visit (45+ min) | 124 | $14,482 | $117 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 249 | $12,950 | $52 |
| Injection, regadenoson, 0.1 mg | 732 | $11,243 | None |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 173 | $10,490 | $20 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 212 | $10,318 | $16 |
| Ultrasound of both sides of head and neck blood flow | 68 | $10,134 | $147 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 38 | $10,092 | $259 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 682 | $9,865 | $11 |
| Ultrasound of leg arteries or artery grafts | 46 | $9,537 | $199 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 1,244 | $8,392 | $6 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 19 | $7,151 | $376 |
| Heart rhythm recording, analysis, report, review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 33 | $6,972 | $211 |
| Telephone medical discussion with physician, 5-10 minutes | 129 | $6,747 | $44 |
| Short return visit (20+ min) | 80 | $5,837 | $70 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 24 | $5,707 | $220 |
| Ultrasound of heart blood flow, valves and chambers | 130 | $5,480 | $42 |
| Nuclear medicine study of heart pumping function by labeling red blood cells with measurement of internal blood volume ejected with every beat over multiple cycles | 32 | $5,398 | $169 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 29 | $4,511 | $156 |
| Injection for imaging of aorta above heart valve with review by radiologist | 153 | $4,393 | $28 |
| External shock to heart to regulate heart beat | 37 | $3,897 | $80 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 49 | $3,762 | $62 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 44 | $3,267 | $26 |
| Ultrasound of heart with probe in esophagus, with report | 35 | $3,057 | $83 |
| Programming of dual lead implantable defibrillator system | 22 | $2,831 | $69 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 130 | $2,570 | $20 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 217 | $2,290 | $9 |
| New patient visit (60+ min) | 13 | $2,145 | $165 |
| Programming of multiple lead implantable defibrillator system | 12 | $1,837 | $80 |
| Infusion, normal saline solution , 1000 cc | 190 | $1,589 | None |
| Injection, aminophyllin, up to 250 mg | 208 | $1,419 | None |
| Telephone medical discussion with physician, 11-20 minutes | 14 | $1,074 | $72 |
| Evaluation of implantable heart and blood vessel monitoring system | 11 | $872 | $44 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 13 | $735 | $57 |
| Electrocardiogram (ecg) 2-day continuous | 45 | $727 | $15 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 55 | $717 | $13 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 45 | $685 | $14 |
| Ultrasound of heart, follow-up | 30 | $641 | $19 |
| Ultrasound of heart blood flow, valves and chambers | 36 | $541 | $14 |
| Blood test, clotting time | 14 | $475 | $4 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 27 | $467 | $17 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 27 | $261 | $10 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 62 | $162 | $2 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 27 | $156 | $5 |
Procedures Medicare counted
| Coronary angioplasty and stenting | 68 | More than 90% of doctors who do this |
| Pacemaker insertion or repair | 20 | More than 71% of doctors who do this |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Insertion of pacemaker and upper and lower heart chamber electrode | 33 | 22 | 32 | 33 | 18 | 19 |
| Insertion of heart rhythm monitor under skin | 15 | 34 | 23 | 12 | 11 | 13 |
| Insertion of tube into abdominal, pelvic, or leg artery, initial third order branch | – | 14 | 11 | – | – | – |
| Removal and replacement of dual lead permanent pacemaker | – | – | – | – | 11 | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
3,190 Original Medicare patients in 2024. Average age 76 · Under 65 7% · 85 and older 19% · Women 53% · Also on Medicaid 32% · Health risk score 1.81. Above the middle of the specialty; the typical interventional cardiology clinician is at 1.7.
Conditions among them: High blood pressure 75% · Coronary heart disease 50% · Diabetes 49% · Chronic kidney disease 43% · Heart failure 33% · Atrial fibrillation 29% · Depression 23% · COPD 20% · Cancer 16% · Dementia 13% · Stroke 12%.
The office billed $7,295,373, Medicare allowed $2,687,531 and paid $2,081,036; for 19,705 services of 119 kinds; $14,251 of it was for drugs given in the office and $2,066,785 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 3,190 | 19,705 | 76 | 1.81 | $7,295,373 | $2,081,036 |
| 2023 | 3,084 | 19,597 | 76 | 1.64 | $5,201,494 | $1,479,141 |
| 2022 | 3,357 | 18,819 | 76 | 1.60 | $5,252,972 | $1,519,770 |
| 2021 | 2,966 | 17,998 | 76 | 1.72 | $5,219,761 | $1,631,958 |
| 2020 | 2,983 | 18,971 | 75 | 1.81 | $5,784,689 | $1,785,047 |
| 2019 | 3,771 | 20,528 | 75 | 1.85 | $5,786,671 | $1,734,209 |
| 2018 | 3,264 | 20,359 | 75 | 1.78 | $5,730,345 | $1,712,553 |
| 2017 | 2,897 | 19,627 | 75 | 1.79 | $5,751,726 | $1,773,297 |
| 2016 | 2,206 | 19,720 | 75 | 1.60 | $6,097,186 | $1,942,556 |
| 2015 | 2,183 | 20,581 | 75 | 1.53 | $6,716,608 | $2,186,631 |
| 2014 | 2,050 | 19,977 | 75 | 1.39 | $6,874,993 | $2,217,930 |
| 2013 | 2,042 | 20,119 | 75 | 1.38 | $6,633,561 | $2,114,177 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 58 services
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 882 | $326,416 | $363 |
| Return visit (30+ min) | 1,633 | $278,275 | $94 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 872 | $132,036 | $149 |
| Injection, regadenoson, 0.1 mg | 584 | $98,746 | None |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 878 | $84,817 | $47 |
| Long return visit (40+ min) | 381 | $77,549 | $137 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 1,039 | $51,210 | $47 |
| Insertion of heart rhythm monitor under skin | 11 | $41,058 | $3,733 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 197 | $32,668 | $166 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 122 | $20,945 | $94 |
| New patient visit (45+ min) | 181 | $20,818 | $115 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 149 | $20,593 | $135 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 97 | $18,022 | $182 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 33 | $17,209 | $420 |
| Programming of dual lead pacemaker system | 139 | $15,665 | $59 |
| Ultrasound of both sides of head and neck blood flow | 90 | $13,112 | $146 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 241 | $12,779 | $53 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 67 | $11,531 | $20 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 739 | $10,638 | $11 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 199 | $10,410 | $17 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 165 | $10,271 | $21 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 35 | $9,762 | $279 |
| Ultrasound of leg arteries or artery grafts | 48 | $8,565 | $178 |
| Ultrasound of heart blood flow, valves and chambers | 200 | $8,418 | $42 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 11 | $7,652 | $696 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 18 | $7,214 | $401 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 1,042 | $6,954 | $6 |
| Nuclear medicine study of heart pumping function by labeling red blood cells with measurement of internal blood volume ejected with every beat over multiple cycles | 39 | $6,713 | $172 |
| Short return visit (20+ min) | 105 | $6,502 | $61 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 42 | $6,423 | $149 |
| Telephone medical discussion with physician, 5-10 minutes | 125 | $5,984 | $44 |
| External shock to heart to regulate heart beat | 45 | $4,606 | $85 |
| Injection for imaging of aorta above heart valve with review by radiologist | 150 | $4,357 | $28 |
| New patient visit (60+ min) | 27 | $4,218 | $156 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 33 | $3,975 | $20 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 200 | $3,961 | $20 |
| Ultrasound of heart with probe in esophagus, with report | 44 | $3,733 | $85 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 12 | $3,264 | $251 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 41 | $3,148 | $26 |
| Removal and replacement of dual lead permanent pacemaker | 11 | $2,976 | $271 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 213 | $2,258 | $10 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 23 | $2,080 | $63 |
| Telephone medical discussion with physician, 11-20 minutes | 28 | $2,045 | $68 |
| Programming of multiple lead implantable defibrillator system | 14 | $1,771 | $84 |
| Programming of dual lead implantable defibrillator system | 19 | $1,725 | $69 |
| Electrocardiogram (ecg) 2-day continuous | 97 | $1,501 | $15 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 99 | $1,459 | $14 |
| Infusion, normal saline solution , 1000 cc | 180 | $1,435 | None |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 48 | $903 | $18 |
| Blood test, clotting time | 24 | $815 | $4 |
| Evaluation of cardiac rhythm monitor system | 15 | $722 | $38 |
| Ultrasound of heart blood flow, valves and chambers | 47 | $667 | $14 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 48 | $486 | $10 |
| Ultrasound of heart, follow-up | 22 | $436 | $20 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 11 | $397 | $33 |
| Injection, aminophyllin, up to 250 mg | 42 | $349 | None |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 68 | $168 | $2 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 18 | $102 | $6 |
2022: 61 services
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 803 | $308,074 | $379 |
| Return visit (30+ min) | 1,563 | $249,430 | $97 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 1,050 | $162,357 | $152 |
| Injection, regadenoson, 0.1 mg | 553 | $106,296 | None |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 802 | $79,693 | $49 |
| Long return visit (40+ min) | 357 | $73,286 | $141 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 1,004 | $52,048 | $50 |
| Insertion of heart rhythm monitor under skin | 12 | $47,842 | $3,987 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 239 | $40,040 | $168 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 202 | $33,059 | $159 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 181 | $29,861 | $81 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 44 | $21,196 | $433 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 101 | $19,908 | $193 |
| New patient visit (45+ min) | 162 | $19,265 | $119 |
| Ultrasound of both sides of head and neck blood flow | 120 | $18,932 | $156 |
| Programming of dual lead pacemaker system | 147 | $16,669 | $63 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 33 | $13,658 | $414 |
| Short return visit (20+ min) | 165 | $13,569 | $71 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 242 | $13,318 | $55 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 85 | $12,487 | $20 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 844 | $12,150 | $11 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 218 | $11,422 | $18 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 186 | $11,284 | $21 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 41 | $11,160 | $272 |
| Ultrasound of heart blood flow, valves and chambers | 239 | $10,364 | $43 |
| Ultrasound of leg arteries or artery grafts | 53 | $10,110 | $191 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 1,219 | $8,639 | $6 |
| Nuclear medicine study of heart pumping function by labeling red blood cells with measurement of internal blood volume ejected with every beat over multiple cycles | 43 | $7,290 | $170 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 86 | $7,229 | $57 |
| Injection for imaging of aorta above heart valve with review by radiologist | 169 | $6,901 | $40 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 25 | $5,788 | $223 |
| External shock to heart to regulate heart beat | 52 | $5,163 | $85 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 239 | $4,865 | $20 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 27 | $4,108 | $152 |
| New patient visit (60+ min) | 21 | $3,644 | $174 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 46 | $3,302 | $27 |
| Telephone medical discussion with physician, 11-20 minutes | 50 | $3,140 | $62 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 19 | $2,860 | $151 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 243 | $2,718 | $10 |
| Ultrasound of heart with probe in esophagus, with report | 33 | $2,703 | $82 |
| Telephone medical discussion with physician, 5-10 minutes | 53 | $2,481 | $46 |
| Telephone medical discussion with physician, 21-30 minutes | 26 | $2,460 | $91 |
| Programming of dual lead implantable defibrillator system | 22 | $2,166 | $75 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 17 | $2,146 | $19 |
| Electrocardiogram (ecg) 2-day continuous | 121 | $1,961 | $16 |
| Programming of multiple lead implantable defibrillator system | 12 | $1,919 | $80 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 121 | $1,808 | $14 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 14 | $1,520 | $109 |
| Complete ultrasound study of arm and leg arteries | 12 | $969 | $81 |
| Evaluation of cardiac rhythm monitor system | 19 | $959 | $40 |
| New patient visit (30+ min) | 12 | $933 | $78 |
| Evaluation of implantable heart and blood vessel monitoring system | 12 | $930 | $47 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 21 | $893 | $41 |
| Blood test, clotting time | 22 | $771 | $4 |
| Ultrasound of heart blood flow, valves and chambers | 38 | $559 | $14 |
| Ultrasound of heart, follow-up | 25 | $511 | $20 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 24 | $476 | $20 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 24 | $290 | $12 |
| Smoking and tobacco use intensive counseling, 4-10 minutes | 14 | $205 | $15 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 61 | $156 | $3 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 19 | $111 | $6 |
2021: 61 services
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 672 | $273,601 | $403 |
| Return visit (30+ min) | 1,385 | $247,090 | $103 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 882 | $143,857 | $161 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 671 | $121,461 | $90 |
| Insertion of heart rhythm monitor under skin | 23 | $101,648 | $4,419 |
| Injection, regadenoson, 0.1 mg | 501 | $94,868 | None |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 307 | $57,282 | $187 |
| Long return visit (40+ min) | 239 | $50,789 | $145 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 191 | $43,926 | $83 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 814 | $42,807 | $51 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 219 | $38,652 | $160 |
| New patient visit (45+ min) | 213 | $26,876 | $126 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 45 | $23,763 | $440 |
| Programming of dual lead pacemaker system | 211 | $21,990 | $62 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 105 | $21,049 | $190 |
| Ultrasound of both sides of head and neck blood flow | 127 | $21,008 | $164 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 339 | $19,543 | $57 |
| Telephone medical discussion with physician, 21-30 minutes | 147 | $17,509 | $108 |
| Telephone medical discussion with physician, 11-20 minutes | 188 | $14,504 | $68 |
| Ultrasound of heart blood flow, valves and chambers | 308 | $14,079 | $46 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 49 | $13,682 | $274 |
| Insertion of tube into abdominal, pelvic, or leg artery, initial third order branch | 11 | $13,675 | $1,243 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 32 | $13,128 | $410 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 80 | $12,473 | $21 |
| Short return visit (20+ min) | 144 | $11,455 | $69 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 673 | $11,401 | $12 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 217 | $10,246 | $20 |
| Ultrasound of leg arteries or artery grafts | 44 | $9,191 | $209 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 170 | $9,174 | $23 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 78 | $7,541 | $58 |
| Injection for imaging of aorta above heart valve with review by radiologist | 171 | $7,302 | $41 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 930 | $7,144 | $6 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 308 | $6,659 | $22 |
| Complete ultrasound study of arm and leg arteries | 64 | $6,053 | $95 |
| Nuclear medicine study of heart pumping function by labeling red blood cells with measurement of internal blood volume ejected with every beat over multiple cycles | 31 | $5,841 | $188 |
| External shock to heart to regulate heart beat | 51 | $5,719 | $89 |
| Ultrasound of heart with probe in esophagus, with report | 54 | $5,009 | $88 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 28 | $4,939 | $165 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 21 | $4,761 | $216 |
| New patient visit (60+ min) | 20 | $3,668 | $183 |
| Programming of dual lead implantable defibrillator system | 32 | $3,409 | $79 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 54 | $3,068 | $28 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 20 | $3,031 | $20 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 261 | $3,004 | $10 |
| Programming of multiple lead implantable defibrillator system | 23 | $2,916 | $79 |
| Evaluation of implantable heart and blood vessel monitoring system | 34 | $2,275 | $40 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 14 | $2,170 | $155 |
| Electrocardiogram (ecg) 2-day continuous | 117 | $2,036 | $17 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 119 | $1,892 | $15 |
| Evaluation of cardiac rhythm monitor system | 26 | $1,279 | $41 |
| Programming of single lead implantable defibrillator system | 11 | $1,264 | $55 |
| Review by radiologist of abdominal aorta image | 12 | $1,225 | $102 |
| Programming of single lead pacemaker system | 12 | $1,013 | $46 |
| Blood test, clotting time | 37 | $918 | $4 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 16 | $843 | $47 |
| Ultrasound of heart blood flow, valves and chambers | 53 | $835 | $15 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 14 | $577 | $41 |
| Ultrasound of heart, follow-up | 14 | $292 | $21 |
| Smoking and tobacco use intensive counseling, 4-10 minutes | 14 | $241 | $15 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 63 | $172 | $3 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 12 | $164 | $9 |
2020: 68 services
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 744 | $304,603 | $407 |
| Return visit (30+ min) | 1,518 | $232,576 | $88 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 973 | $161,417 | $163 |
| Insertion of heart rhythm monitor under skin | 34 | $151,779 | $4,464 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 746 | $145,807 | $97 |
| Injection, regadenoson, 0.1 mg | 573 | $107,307 | None |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 363 | $67,871 | $187 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 175 | $44,730 | $87 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 833 | $43,727 | $51 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 194 | $35,281 | $166 |
| Long return visit (40+ min) | 197 | $33,142 | $116 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 59 | $32,469 | $439 |
| Short return visit (20+ min) | 348 | $26,152 | $58 |
| Programming of dual lead pacemaker system | 217 | $21,321 | $56 |
| New patient visit (45+ min) | 163 | $20,957 | $129 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 105 | $20,056 | $187 |
| Ultrasound of both sides of head and neck blood flow | 119 | $20,023 | $167 |
| Insertion of tube into abdominal, pelvic, or leg artery, initial third order branch | 14 | $17,554 | $1,254 |
| Ultrasound of heart blood flow, valves and chambers | 368 | $17,002 | $46 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 59 | $16,698 | $283 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 212 | $12,969 | $61 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 606 | $11,904 | $14 |
| Telephone medical discussion with physician, 11-20 minutes | 165 | $11,328 | $63 |
| Ultrasound of leg arteries or artery grafts | 46 | $9,981 | $208 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 22 | $9,431 | $429 |
| Telephone medical discussion with physician, 21-30 minutes | 98 | $9,070 | $87 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 189 | $8,961 | $20 |
| Injection for imaging of aorta above heart valve with review by radiologist | 199 | $8,797 | $43 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 149 | $8,367 | $23 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 62 | $8,322 | $21 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 1,030 | $8,201 | $6 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 30 | $8,051 | $244 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 368 | $7,984 | $22 |
| Nuclear medicine study of heart pumping function by labeling red blood cells with measurement of internal blood volume ejected with every beat over multiple cycles | 40 | $7,727 | $193 |
| Complete ultrasound study of arm and leg arteries | 77 | $7,651 | $97 |
| Ultrasound of heart with probe in esophagus, with report | 65 | $6,498 | $93 |
| External shock to heart to regulate heart beat | 55 | $6,195 | $90 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 63 | $5,020 | $60 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 28 | $4,500 | $161 |
| Programming of multiple lead implantable defibrillator system | 22 | $3,653 | $78 |
| Programming of dual lead implantable defibrillator system | 37 | $3,599 | $69 |
| Insertion of tube in right and left heart chambers, coronary artery, and bypass graft for diagnosis with review by radiologist | 11 | $3,275 | $298 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 283 | $3,229 | $10 |
| New patient visit (60+ min) | 17 | $2,957 | $174 |
| Electrocardiogram (ecg) 2-day continuous | 117 | $2,618 | $22 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 116 | $2,617 | $22 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 43 | $2,546 | $29 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 16 | $2,277 | $142 |
| Review by radiologist of both arms or legs arteries image | 14 | $2,083 | $149 |
| Initial hospital observation care per day, typically 70 minutes | 13 | $1,998 | $154 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 19 | $1,883 | $19 |
| Review by radiologist of abdominal aorta image | 15 | $1,842 | $115 |
| Short return visit (20+ min) | 39 | $1,711 | $42 |
| Evaluation of implantable heart and blood vessel monitoring system | 28 | $1,630 | $38 |
| Follow-up observation care per day, typically 35 minutes | 14 | $1,589 | $84 |
| Blood test, clotting time | 48 | $1,304 | $4 |
| Programming of single lead pacemaker system | 15 | $1,260 | $43 |
| Programming of single lead implantable defibrillator system | 11 | $1,148 | $55 |
| Evaluation of cardiac rhythm monitor system | 31 | $1,123 | $36 |
| Ultrasound of heart blood flow, valves and chambers | 61 | $1,026 | $16 |
| New patient visit (30+ min) | 11 | $928 | $84 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 18 | $819 | $43 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 17 | $519 | $9 |
| Ultrasound of heart, follow-up | 17 | $388 | $22 |
| Anticoagulant management of patient taking warfarin | 13 | $325 | $8 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 68 | $198 | $3 |
| Smoking and tobacco use intensive counseling, 4-10 minutes | 12 | $192 | $16 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician | 12 | $129 | $11 |
2019: 61 services
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 738 | $305,654 | $406 |
| Return visit (30+ min) | 1,541 | $211,717 | $87 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 1,009 | $173,068 | $165 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 746 | $145,764 | $96 |
| Injection, regadenoson, 0.1 mg | 591 | $108,886 | None |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 373 | $68,214 | $183 |
| Insertion of heart rhythm monitor under skin | 15 | $63,503 | $4,234 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 278 | $60,846 | $85 |
| Long return visit (40+ min) | 302 | $54,129 | $117 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 273 | $48,232 | $165 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 840 | $43,915 | $50 |
| Short return visit (20+ min) | 401 | $29,925 | $53 |
| New patient visit (45+ min) | 208 | $26,709 | $128 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 49 | $25,792 | $461 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 108 | $22,548 | $203 |
| Programming of dual lead pacemaker system | 227 | $22,239 | $50 |
| Ultrasound of both sides of head and neck blood flow | 132 | $22,059 | $167 |
| Ultrasound of heart blood flow, valves and chambers | 375 | $17,056 | $45 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 253 | $15,162 | $59 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 1,712 | $14,762 | $7 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 33 | $14,031 | $425 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 48 | $13,317 | $272 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 677 | $12,708 | $14 |
| Complete ultrasound study of arm and leg arteries | 97 | $9,553 | $96 |
| Ultrasound of leg arteries or artery grafts | 42 | $8,816 | $205 |
| Injection for imaging of aorta above heart valve with review by radiologist | 195 | $8,449 | $42 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 375 | $8,095 | $22 |
| Ultrasound of heart with probe in esophagus, with report | 71 | $7,045 | $90 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 154 | $6,591 | $20 |
| Nuclear medicine study of heart pumping function by labeling red blood cells with measurement of internal blood volume ejected with every beat over multiple cycles | 35 | $6,414 | $183 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 123 | $6,008 | $22 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 74 | $5,961 | $60 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 35 | $5,608 | $160 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 26 | $5,333 | $198 |
| New patient visit (60+ min) | 33 | $5,310 | $161 |
| External shock to heart to regulate heart beat | 50 | $5,118 | $90 |
| Programming of dual lead implantable defibrillator system | 42 | $4,599 | $65 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 32 | $4,228 | $21 |
| Insertion of tube in right and left heart chambers, coronary artery, and bypass graft for diagnosis with review by radiologist | 14 | $4,064 | $271 |
| Programming of multiple lead implantable defibrillator system | 24 | $4,002 | $74 |
| Remote evaluations of implantable heart and blood vessel monitor or loop recorder system with technician analysis, review, and report, up to 30 days | 58 | $3,518 | $10 |
| Initial hospital observation care per day, typically 70 minutes | 22 | $3,347 | $152 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 278 | $3,121 | $10 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 26 | $3,019 | $20 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 141 | $2,985 | $21 |
| Electrocardiogram (ecg) 2-day continuous | 138 | $2,957 | $21 |
| Follow-up observation care per day, typically 35 minutes | 27 | $2,901 | $83 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 32 | $1,983 | $33 |
| Evaluation of implantable heart and blood vessel monitoring system | 25 | $1,672 | $36 |
| Short return visit (20+ min) | 37 | $1,634 | $42 |
| Programming of single lead pacemaker system | 21 | $1,613 | $44 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 13 | $1,455 | $112 |
| Blood test, clotting time | 41 | $1,220 | $4 |
| Ultrasound of heart blood flow, valves and chambers | 68 | $1,146 | $15 |
| Evaluation of cardiac rhythm monitor system | 12 | $546 | $32 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 13 | $487 | $37 |
| Short return visit | 16 | $468 | $29 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician | 28 | $328 | $10 |
| Ultrasound of heart, follow-up | 12 | $255 | $21 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 75 | $221 | $3 |
| Smoking and tobacco use intensive counseling, 4-10 minutes | 14 | $215 | $14 |
2018: 63 services
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 782 | $327,483 | $407 |
| Return visit (30+ min) | 1,449 | $184,166 | $85 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 1,051 | $183,112 | $166 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 784 | $152,130 | $94 |
| Injection, regadenoson, 0.1 mg | 609 | $109,109 | None |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 364 | $65,503 | $179 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 249 | $62,609 | $84 |
| Long return visit (40+ min) | 329 | $54,530 | $115 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 882 | $46,234 | $49 |
| Short return visit (20+ min) | 568 | $44,370 | $55 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 243 | $43,488 | $163 |
| Ultrasound of both sides of head and neck blood flow | 166 | $28,000 | $168 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 128 | $26,803 | $203 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 49 | $26,029 | $441 |
| New patient visit (45+ min) | 184 | $23,656 | $129 |
| Insertion of tube into abdominal, pelvic, or leg artery, initial third order branch | 16 | $19,487 | $1,218 |
| Programming of dual lead pacemaker system | 205 | $18,257 | $44 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 61 | $17,597 | $279 |
| Ultrasound of heart blood flow, valves and chambers | 364 | $16,621 | $46 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 198 | $12,039 | $60 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 1,261 | $10,624 | $7 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 26 | $10,387 | $399 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 566 | $9,925 | $13 |
| Injection for imaging of aorta above heart valve with review by radiologist | 220 | $9,519 | $42 |
| Complete ultrasound study of arm and leg arteries | 89 | $9,348 | $98 |
| Nuclear medicine study of heart pumping function by labeling red blood cells with measurement of internal blood volume ejected with every beat over multiple cycles | 46 | $8,981 | $191 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 363 | $7,967 | $22 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 33 | $7,260 | $220 |
| Ultrasound of heart with probe in esophagus, with report | 64 | $6,888 | $89 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 149 | $6,635 | $21 |
| Ultrasound of leg arteries or artery grafts | 30 | $6,598 | $200 |
| External shock to heart to regulate heart beat | 61 | $6,308 | $90 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 38 | $5,879 | $20 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 65 | $5,476 | $59 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 113 | $5,458 | $22 |
| Removal and replacement of dual lead permanent pacemaker | 19 | $5,404 | $284 |
| Initial hospital observation care per day, typically 70 minutes | 28 | $4,220 | $151 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 23 | $3,993 | $166 |
| Remote evaluations of implantable heart and blood vessel monitor or loop recorder system with technician analysis, review, and report, up to 30 days | 54 | $3,750 | $10 |
| New patient visit (60+ min) | 26 | $3,726 | $143 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 152 | $3,630 | $22 |
| Electrocardiogram (ecg) 2-day continuous | 151 | $3,609 | $22 |
| Review by radiologist of both arms or legs arteries image | 19 | $3,555 | $162 |
| Programming of dual lead implantable defibrillator system | 33 | $3,510 | $61 |
| Programming of multiple lead implantable defibrillator system | 24 | $3,310 | $65 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 37 | $3,288 | $41 |
| Short return visit | 76 | $2,961 | $36 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 257 | $2,916 | $10 |
| Short return visit (20+ min) | 51 | $2,280 | $41 |
| Review by radiologist of abdominal aorta image | 17 | $2,274 | $114 |
| Programming of single lead pacemaker system | 28 | $2,166 | $37 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 16 | $1,941 | $21 |
| Evaluation of implantable heart and blood vessel monitoring system | 37 | $1,766 | $29 |
| Blood test, clotting time | 75 | $1,667 | $5 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 11 | $1,213 | $110 |
| Return visit (30+ min) | 16 | $1,208 | $64 |
| Ultrasound of heart blood flow, valves and chambers | 61 | $1,112 | $15 |
| Programming of single lead implantable defibrillator system | 11 | $1,109 | $50 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician | 59 | $750 | $10 |
| Anticoagulant management of patient taking warfarin | 21 | $611 | $10 |
| Review by radiologist of abdominal aorta image | 11 | $489 | $44 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 16 | $479 | $30 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 64 | $202 | $3 |
2017: 63 services
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 879 | $366,434 | $403 |
| Return visit (30+ min) | 1,396 | $189,371 | $83 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 959 | $181,612 | $182 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 879 | $170,816 | $94 |
| Injection, regadenoson, 0.1 mg | 649 | $113,923 | None |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 296 | $63,111 | $212 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 955 | $51,015 | $50 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 193 | $49,591 | $84 |
| Long return visit (40+ min) | 265 | $48,678 | $116 |
| Short return visit (20+ min) | 572 | $43,387 | $56 |
| Ultrasound of both sides of head and neck blood flow | 196 | $32,907 | $165 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 176 | $31,360 | $163 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 42 | $22,007 | $440 |
| New patient visit (45+ min) | 167 | $20,059 | $120 |
| Programming of dual lead pacemaker system | 208 | $19,516 | $43 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 97 | $19,358 | $198 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 61 | $17,289 | $283 |
| Insertion of tube into abdominal, pelvic, or leg artery, initial third order branch | 13 | $17,085 | $1,220 |
| Ultrasound of heart blood flow, valves and chambers | 296 | $13,414 | $45 |
| Ultrasound of leg arteries or artery grafts | 55 | $12,712 | $215 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 569 | $10,086 | $14 |
| Complete ultrasound study of arm and leg arteries | 94 | $9,584 | $96 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 1,076 | $9,570 | $7 |
| Nuclear medicine study of heart pumping function by labeling red blood cells with measurement of internal blood volume ejected with every beat over multiple cycles | 50 | $9,243 | $185 |
| Injection for imaging of aorta above heart valve with review by radiologist | 194 | $8,348 | $42 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 20 | $8,193 | $410 |
| External shock to heart to regulate heart beat | 63 | $6,719 | $90 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 146 | $6,630 | $20 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 296 | $6,386 | $22 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 113 | $6,087 | $24 |
| Insertion of tube in right and left heart chambers, coronary artery, and bypass graft for diagnosis with review by radiologist | 22 | $6,037 | $274 |
| Critical care, first 30-74 minutes | 18 | $5,393 | $180 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 34 | $5,328 | $21 |
| Ultrasound of heart with probe in esophagus, with report | 53 | $4,751 | $86 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 94 | $4,746 | $50 |
| Programming of multiple lead implantable defibrillator system | 33 | $4,416 | $72 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 191 | $4,347 | $22 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 16 | $4,335 | $241 |
| Electrocardiogram (ecg) 2-day continuous | 190 | $4,276 | $21 |
| New patient visit (60+ min) | 25 | $4,063 | $163 |
| Removal and replacement of dual lead permanent pacemaker | 14 | $3,880 | $277 |
| Programming of dual lead implantable defibrillator system | 35 | $3,857 | $60 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 39 | $3,837 | $50 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 52 | $3,691 | $59 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 22 | $3,680 | $167 |
| Review by radiologist of both arms or legs arteries image | 19 | $3,273 | $156 |
| Remote evaluations of implantable heart and blood vessel monitor or loop recorder system with technician analysis, review, and report, up to 30 days | 45 | $3,167 | $10 |
| Review by radiologist of abdominal aorta image | 20 | $2,398 | $114 |
| Implantation patient-activated heart monitoring device | 13 | $2,385 | $183 |
| Short return visit (20+ min) | 45 | $2,272 | $40 |
| Blood test, clotting time | 72 | $2,133 | $5 |
| Programming of single lead pacemaker system | 33 | $1,997 | $34 |
| Evaluation of implantable heart and blood vessel monitoring system | 33 | $1,405 | $25 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 11 | $1,328 | $111 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 11 | $1,326 | $21 |
| Programming of single lead implantable defibrillator system | 11 | $1,190 | $52 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician | 80 | $1,044 | $10 |
| Pulmonary exercise testing | 17 | $1,029 | $47 |
| Review by radiologist of abdominal aorta image | 17 | $761 | $45 |
| Ultrasound of heart blood flow, valves and chambers | 48 | $728 | $15 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 21 | $558 | $25 |
| Evaluation of cardiac rhythm monitor system | 13 | $549 | $29 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 53 | $140 | $3 |
2016: 59 services
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 1,107 | $461,239 | $405 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 1,140 | $217,353 | $181 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 1,107 | $214,356 | $94 |
| Return visit (30+ min) | 1,481 | $201,423 | $85 |
| Injection, regadenoson, 0.1 mg | 812 | $139,161 | None |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 1,167 | $62,874 | $51 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 283 | $59,574 | $210 |
| Long return visit (40+ min) | 275 | $43,825 | $114 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 171 | $42,467 | $84 |
| Short return visit (20+ min) | 516 | $39,968 | $57 |
| Ultrasound of both sides of head and neck blood flow | 212 | $34,452 | $157 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 55 | $33,369 | $445 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 179 | $32,648 | $164 |
| Programming of dual lead pacemaker system | 234 | $23,450 | $44 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 106 | $22,863 | $206 |
| New patient visit (45+ min) | 167 | $20,653 | $124 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 71 | $19,878 | $280 |
| Insertion of tube into abdominal, pelvic, or leg artery, initial third order branch | 15 | $18,156 | $1,210 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 37 | $15,891 | $429 |
| Ultrasound of heart blood flow, valves and chambers | 283 | $12,839 | $45 |
| Nuclear medicine study of heart pumping function by labeling red blood cells with measurement of internal blood volume ejected with every beat over multiple cycles | 59 | $11,674 | $195 |
| Complete ultrasound study of arm and leg arteries | 92 | $10,212 | $98 |
| Injection for imaging of aorta above heart valve with review by radiologist | 207 | $8,917 | $42 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 106 | $7,690 | $69 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 410 | $6,968 | $14 |
| External shock to heart to regulate heart beat | 58 | $6,731 | $99 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 283 | $6,124 | $22 |
| Insertion of tube in right and left heart chambers, coronary artery, and bypass graft for diagnosis with review by radiologist | 19 | $5,916 | $311 |
| Ultrasound of leg arteries or artery grafts | 31 | $5,895 | $159 |
| New patient visit (60+ min) | 35 | $5,722 | $163 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 120 | $5,127 | $19 |
| Ultrasound of heart with probe in esophagus, with report | 50 | $5,068 | $99 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 91 | $4,843 | $52 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 91 | $4,824 | $24 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 30 | $4,720 | $157 |
| Initial hospital observation care per day, typically 70 minutes | 29 | $4,532 | $146 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 56 | $4,209 | $58 |
| Programming of dual lead implantable defibrillator system | 35 | $4,172 | $60 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 17 | $4,107 | $242 |
| Removal and replacement of dual lead permanent pacemaker | 14 | $4,002 | $286 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 31 | $3,415 | $48 |
| Programming of multiple lead implantable defibrillator system | 23 | $3,060 | $68 |
| Short return visit (20+ min) | 59 | $2,828 | $41 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 31 | $2,768 | $18 |
| Review by radiologist of both arms or legs arteries image | 17 | $2,727 | $151 |
| Blood test, clotting time | 67 | $2,710 | $5 |
| Programming of single lead pacemaker system | 34 | $2,374 | $36 |
| Review by radiologist of abdominal aorta image | 17 | $2,007 | $111 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 87 | $1,892 | $22 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 268 | $1,873 | $6 |
| Electrocardiogram (ecg) 2-day continuous | 86 | $1,807 | $21 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician | 91 | $1,479 | $10 |
| Remote evaluations of implantable heart and blood vessel monitor or loop recorder system with technician analysis, review, and report, up to 30 days | 34 | $1,443 | $9 |
| Evaluation of implantable heart and blood vessel monitoring system | 29 | $1,055 | $24 |
| Ultrasound of heart blood flow, valves and chambers | 45 | $694 | $15 |
| Review by radiologist of abdominal aorta image | 11 | $495 | $45 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 14 | $432 | $27 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 15 | $249 | $16 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 50 | $134 | $3 |
2015: 71 services
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 1,074 | $452,153 | $399 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 1,089 | $301,455 | $130 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 1,099 | $215,097 | $181 |
| Return visit (30+ min) | 1,390 | $198,000 | $85 |
| Injection, regadenoson, 0.1 mg | 809 | $137,611 | None |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 339 | $73,061 | $213 |
| Long return visit (40+ min) | 343 | $63,218 | $115 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 1,130 | $60,709 | $50 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 156 | $38,887 | $84 |
| Ultrasound of both sides of head and neck blood flow | 214 | $36,266 | $164 |
| Short return visit (20+ min) | 470 | $35,674 | $55 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 176 | $31,477 | $161 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 53 | $29,054 | $461 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 96 | $28,472 | $297 |
| Programming of dual lead pacemaker system | 232 | $25,839 | $43 |
| Insertion of tube into intracranial artery for diagnosis or treatment with review by radiologist | 13 | $23,012 | $1,046 |
| New patient visit (45+ min) | 172 | $21,568 | $125 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 95 | $21,143 | $216 |
| Insertion of tube into abdominal, pelvic, or leg artery, initial third order branch | 17 | $19,927 | $1,172 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 211 | $15,659 | $69 |
| Ultrasound of heart blood flow, valves and chambers | 339 | $15,496 | $45 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 35 | $14,862 | $425 |
| Nuclear medicine study of heart pumping function by labeling red blood cells with measurement of internal blood volume ejected with every beat over multiple cycles | 69 | $13,767 | $189 |
| Critical care, first 30-74 minutes | 22 | $12,787 | $178 |
| Injection for imaging of aorta above heart valve with review by radiologist | 228 | $9,671 | $41 |
| Insertion of tube in right and left heart chambers, coronary artery, and bypass graft for diagnosis with review by radiologist | 29 | $9,028 | $311 |
| Complete ultrasound study of arm and leg arteries | 82 | $8,663 | $102 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 463 | $8,384 | $14 |
| External shock to heart to regulate heart beat | 64 | $7,654 | $96 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 339 | $7,455 | $22 |
| Ultrasound of heart with probe in esophagus, with report | 73 | $7,437 | $97 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 69 | $7,154 | $58 |
| Initial hospital observation care per day, typically 70 minutes | 43 | $7,033 | $150 |
| Removal and replacement of dual lead permanent pacemaker | 20 | $5,883 | $294 |
| New patient visit (60+ min) | 37 | $5,818 | $157 |
| Ultrasound of leg arteries or artery grafts | 21 | $5,595 | $180 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 100 | $4,940 | $20 |
| Review by radiologist of both arms or legs arteries image | 26 | $4,621 | $154 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 74 | $4,585 | $26 |
| Programming of dual lead implantable defibrillator system | 40 | $4,526 | $62 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 19 | $4,210 | $222 |
| Programming of multiple lead implantable defibrillator system | 25 | $4,185 | $70 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 24 | $4,075 | $157 |
| Review by radiologist of abdominal aorta image | 26 | $3,541 | $114 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 66 | $3,432 | $51 |
| Blood test, clotting time | 96 | $3,381 | $5 |
| Short return visit (20+ min) | 64 | $3,162 | $40 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 28 | $3,153 | $47 |
| Programming of single lead pacemaker system | 39 | $2,887 | $38 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 277 | $2,294 | $7 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 15 | $1,948 | $20 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 13 | $1,858 | $143 |
| Evaluation of single or dual chamber pacing cardioverter-defibrillator and generator at time of implantation or replacement | 14 | $1,852 | $132 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 13 | $1,531 | $109 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician | 100 | $1,505 | $10 |
| Ultrasound of one leg arteries or artery grafts | 11 | $1,386 | $115 |
| Ultrasound of heart blood flow, valves and chambers | 72 | $1,115 | $15 |
| Review by radiologist of chest aorta serial images | 11 | $1,104 | $100 |
| Follow-up observation care per day, typically 35 minutes | 11 | $1,100 | $85 |
| Hospital discharge day management, 30 minutes or less | 18 | $1,061 | $59 |
| Remote evaluations of implantable heart and blood vessel monitor or loop recorder system with technician analysis, review, and report, up to 30 days | 15 | $943 | $10 |
| Hospital observation care on day of discharge | 12 | $763 | $59 |
| Blood test, lipids (cholesterol and triglycerides) | 41 | $631 | $15 |
| Review by radiologist of both arms or legs arteries image | 11 | $568 | $52 |
| Review by radiologist of abdominal aorta image | 12 | $542 | $45 |
| Evaluation of implantable heart and blood vessel monitoring system | 16 | $483 | $20 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 20 | $362 | $16 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 12 | $335 | $26 |
| Blood glucose (sugar) level | 54 | $299 | $5 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 72 | $207 | $3 |
| Injection, dipyridamole, per 10 mg | 14 | $43 | None |
2014: 64 services
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 1,058 | $439,491 | $400 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 1,074 | $294,615 | $130 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 1,122 | $215,383 | $180 |
| Return visit (30+ min) | 1,400 | $189,209 | $85 |
| Injection, regadenoson, 0.1 mg | 780 | $131,562 | None |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 416 | $88,942 | $213 |
| Short return visit (20+ min) | 724 | $68,098 | $58 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 1,109 | $57,306 | $48 |
| Ultrasound of both sides of head and neck blood flow | 262 | $41,561 | $156 |
| Long return visit (40+ min) | 249 | $40,832 | $114 |
| Insertion of tube into intracranial artery for diagnosis or treatment with review by radiologist | 23 | $40,338 | $877 |
| Programming of dual lead pacemaker system | 251 | $29,663 | $43 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 156 | $28,114 | $162 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 136 | $28,029 | $84 |
| Insertion of tube into abdominal, pelvic, or leg artery, initial third order branch | 22 | $27,920 | $1,269 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 52 | $27,271 | $455 |
| New patient visit (45+ min) | 173 | $20,843 | $120 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 69 | $20,761 | $292 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 91 | $19,960 | $208 |
| Ultrasound of heart blood flow, valves and chambers | 415 | $18,635 | $45 |
| Complete ultrasound study of arm and leg arteries | 158 | $16,992 | $101 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 200 | $15,329 | $70 |
| Nuclear medicine study of heart pumping function by labeling red blood cells with measurement of internal blood volume ejected with every beat over multiple cycles | 74 | $13,156 | $173 |
| Critical care, first 30-74 minutes | 18 | $13,074 | $179 |
| External shock to heart to regulate heart beat | 80 | $10,912 | $98 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 22 | $8,926 | $406 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 415 | $8,901 | $21 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 15 | $8,529 | $569 |
| Review by radiologist of both arms or legs arteries image | 39 | $7,784 | $173 |
| Injection for imaging of aorta above heart valve with review by radiologist | 180 | $7,545 | $40 |
| Ultrasound of heart with probe in esophagus, with report | 74 | $7,393 | $85 |
| Initial hospital observation care per day, typically 70 minutes | 49 | $7,127 | $145 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 42 | $6,645 | $158 |
| Programming of dual lead implantable defibrillator system | 43 | $5,912 | $62 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 334 | $5,385 | $13 |
| Removal and replacement of dual lead permanent pacemaker | 17 | $4,941 | $291 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 57 | $4,826 | $58 |
| Review by radiologist of abdominal aorta image | 32 | $4,813 | $127 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 19 | $4,780 | $239 |
| New patient visit (60+ min) | 29 | $4,581 | $158 |
| Short return visit (20+ min) | 83 | $4,514 | $41 |
| Programming of multiple lead implantable defibrillator system | 28 | $4,235 | $67 |
| Ultrasound of leg arteries or artery grafts | 16 | $3,313 | $184 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 75 | $3,074 | $21 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 58 | $2,873 | $26 |
| Review by radiologist of chest aorta serial images | 23 | $2,850 | $124 |
| Blood test, clotting time | 117 | $2,619 | $5 |
| Programming of single lead pacemaker system | 33 | $2,570 | $35 |
| Evaluation of single or dual chamber pacing cardioverter-defibrillator and generator at time of implantation or replacement | 17 | $2,353 | $138 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician | 142 | $2,209 | $10 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 24 | $1,876 | $49 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 13 | $1,643 | $117 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 26 | $1,356 | $52 |
| Hospital discharge day management, 30 minutes or less | 22 | $1,352 | $59 |
| Hospital observation care on day of discharge | 22 | $1,290 | $59 |
| Ultrasound of heart blood flow, valves and chambers | 66 | $1,106 | $15 |
| Follow-up observation care per day, typically 35 minutes | 11 | $1,098 | $84 |
| Evaluation of implantable heart and blood vessel monitoring system | 21 | $850 | $24 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 85 | $841 | $7 |
| Blood test, lipids (cholesterol and triglycerides) | 40 | $689 | $17 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 17 | $362 | $21 |
| Blood glucose (sugar) level | 57 | $333 | $5 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 74 | $242 | $3 |
| Injection, dipyridamole, per 10 mg | 15 | $56 | None |
2013: 68 services
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 1,128 | $488,340 | $414 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 1,151 | $317,330 | $130 |
| Return visit (30+ min) | 1,467 | $210,029 | $84 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 1,189 | $183,436 | $148 |
| Injection, regadenoson, 0.1 mg | 835 | $143,836 | None |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 1,206 | $65,414 | $51 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 355 | $61,595 | $174 |
| Insertion of tube into intracranial artery for diagnosis or treatment with review by radiologist | 26 | $46,707 | $898 |
| Ultrasound of both sides of head and neck blood flow | 251 | $39,449 | $152 |
| Short return visit (20+ min) | 451 | $32,446 | $58 |
| Programming of dual lead pacemaker system | 276 | $31,895 | $41 |
| Insertion of tube into first order main and accessory arteries of both kidneys for imaging with review by radiologist | 24 | $31,182 | $1,199 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 138 | $29,847 | $81 |
| Long return visit (40+ min) | 173 | $27,429 | $112 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 141 | $25,154 | $157 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 48 | $23,039 | $435 |
| New patient visit (45+ min) | 157 | $19,125 | $122 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 234 | $17,539 | $70 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 78 | $16,226 | $203 |
| Complete ultrasound study of arm and leg arteries | 129 | $15,591 | $111 |
| Nuclear medicine study of heart pumping function by labeling red blood cells with measurement of internal blood volume ejected with every beat over multiple cycles | 77 | $15,021 | $193 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 51 | $14,839 | $291 |
| Insertion of tube into abdominal, pelvic, or leg artery, initial third order branch | 11 | $13,924 | $1,266 |
| Ultrasound of heart blood flow, valves and chambers | 355 | $13,147 | $37 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 32 | $12,801 | $400 |
| Insertion of tube into abdominal, pelvic, or leg artery, initial second order branch | 20 | $10,400 | $473 |
| External shock to heart to regulate heart beat | 64 | $8,350 | $95 |
| Review by radiologist of both arms or legs arteries image | 33 | $6,977 | $174 |
| Injection for imaging of aorta above heart valve with review by radiologist | 164 | $6,401 | $38 |
| Removal and replacement of dual lead permanent pacemaker | 23 | $6,250 | $272 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 367 | $6,228 | $14 |
| Programming of dual lead implantable defibrillator system | 46 | $6,148 | $59 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 68 | $6,055 | $57 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 26 | $5,969 | $221 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 355 | $5,880 | $17 |
| Ultrasound of heart with probe in esophagus, with report | 54 | $4,733 | $82 |
| Initial hospital observation care per day, typically 70 minutes | 31 | $4,403 | $138 |
| Insertion of tube in right and left heart chambers, coronary artery, and bypass graft for diagnosis with review by radiologist | 13 | $4,329 | $333 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 25 | $4,110 | $158 |
| New patient visit (60+ min) | 24 | $3,779 | $157 |
| Short return visit (20+ min) | 65 | $3,757 | $40 |
| Programming of multiple lead implantable defibrillator system | 24 | $3,594 | $62 |
| Programming of single lead pacemaker system | 43 | $3,500 | $36 |
| Critical care, first 30-74 minutes | 12 | $3,305 | $174 |
| Review by radiologist of abdominal aorta image | 19 | $2,879 | $125 |
| Blood test, clotting time | 117 | $2,494 | $5 |
| Review by radiologist of chest aorta serial images | 19 | $2,381 | $125 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician | 130 | $2,300 | $10 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 61 | $2,224 | $20 |
| Evaluation of single or dual chamber pacing cardioverter-defibrillator and generator at time of implantation or replacement | 16 | $2,110 | $132 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 22 | $1,862 | $52 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 42 | $1,728 | $23 |
| Hospital discharge day management, 30 minutes or less | 29 | $1,664 | $57 |
| Programming of single lead implantable defibrillator system | 13 | $1,478 | $48 |
| Blood test, lipids (cholesterol and triglycerides) | 116 | $1,446 | $12 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 11 | $1,192 | $108 |
| Programming of single, dual, or multiple lead or leadless pacemaker system before or after surgery | 57 | $1,068 | $12 |
| Hospital observation care on day of discharge | 17 | $888 | $52 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 17 | $856 | $50 |
| Evaluation of implantable heart and blood vessel monitoring system | 20 | $722 | $24 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 23 | $668 | $27 |
| Blood glucose (sugar) level | 147 | $666 | $4 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 23 | $477 | $13 |
| Liver enzyme (sgpt), level | 95 | $469 | $5 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 61 | $425 | $6 |
| Programming of single, dual or multiple lead implantable defibrillator system before or after surgery | 16 | $402 | $17 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 51 | $159 | $3 |
| Injection, dipyridamole, per 10 mg | 27 | $102 | None |
Medicaid work
$14,823 in 2024
Medicaid paid $14,823 for 2,560 billed services this clinician did in 2024, up to 135 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 233 | $5,317 |
| Return visit (30+ min) | 450 | $3,421 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 1,220 | $2,449 |
| CARDIOVASCULAR STRESS TEST | 189 | $988 |
| Myocardial perfusion imaging, tomographic (SPECT) (including attenuation correction, qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional quantification, when performed); multiple studies, at rest and/or stress (exercise or pharmacologic) and/or redistribution and/or rest reinjection | 55 | $838 |
| Long return visit (40+ min) | 54 | $570 |
| Injection, regadenoson, 0.1 mg | 76 | $383 |
| Tc99m sestamibi | 55 | $356 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 175 | $338 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead pacemaker system, leadless pacemaker system, or implantable defibrillator system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | 41 | $128 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead pacemaker system, or leadless pacemaker system with interim analysis, review(s) and report(s) by a physician or other qualified health care professional | 12 | $33 |
| 2024 | 2,560 | 11 | 135 | $14,823 |
| 2023 | 3,689 | 12 | 215 | $19,598 |
| 2022 | 2,804 | 11 | 152 | $6,465 |
| 2021 | 1,477 | 8 | 41 | $5,470 |
| 2020 | 1,319 | 8 | 32 | $5,970 |
| 2019 | 1,647 | 10 | 49 | $10,100 |
| 2018 | 2,782 | 13 | 107 | $19,067 |
See the largest Medicaid services in earlier years
2023
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 340 | $6,750 |
| Injection, regadenoson, 0.1 mg | 113 | $2,249 |
| CARDIOVASCULAR STRESS TEST | 294 | $2,222 |
| Tc99m sestamibi | 218 | $2,157 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 1,413 | $1,902 |
| Return visit (30+ min) | 597 | $1,338 |
| Myocardial perfusion imaging, tomographic (SPECT) (including attenuation correction, qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional quantification, when performed); multiple studies, at rest and/or stress (exercise or pharmacologic) and/or redistribution and/or rest reinjection | 223 | $1,225 |
| Long return visit (40+ min) | 121 | $512 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 295 | $479 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 22 | $412 |
| 1ST HOSP IP/OBS HIGH 75 | 27 | $255 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead pacemaker system, leadless pacemaker system, or implantable defibrillator system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | 26 | $96 |
2022
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 310 | $1,662 |
| Myocardial perfusion imaging, tomographic (SPECT) (including attenuation correction, qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional quantification, when performed); multiple studies, at rest and/or stress (exercise or pharmacologic) and/or redistribution and/or rest reinjection | 151 | $1,097 |
| CARDIOVASCULAR STRESS TEST | 240 | $969 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 1,236 | $817 |
| Tc99m sestamibi | 150 | $699 |
| Return visit (30+ min) | 349 | $561 |
| Injection, regadenoson, 0.1 mg | 83 | $416 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 182 | $198 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead pacemaker system, leadless pacemaker system, or implantable defibrillator system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | 62 | $45 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead pacemaker system, or leadless pacemaker system with interim analysis, review(s) and report(s) by a physician or other qualified health care professional | 26 | $3 |
| Long return visit (40+ min) | 15 | $0 |
2021
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 304 | $2,720 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 388 | $1,360 |
| Return visit (30+ min) | 208 | $864 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 164 | $296 |
| CARDIOVASCULAR STRESS TEST | 139 | $129 |
| Injection, regadenoson, 0.1 mg | 68 | $76 |
| Tc99m sestamibi | 103 | $24 |
| Myocardial perfusion imaging, tomographic (SPECT) (including attenuation correction, qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional quantification, when performed); multiple studies, at rest and/or stress (exercise or pharmacologic) and/or redistribution and/or rest reinjection | 103 | $0 |
2020
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 298 | $2,209 |
| Return visit (30+ min) | 298 | $2,083 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 118 | $702 |
| Myocardial perfusion imaging, tomographic (SPECT) (including attenuation correction, qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional quantification, when performed); multiple studies, at rest and/or stress (exercise or pharmacologic) and/or redistribution and/or rest reinjection | 136 | $313 |
| CARDIOVASCULAR STRESS TEST | 155 | $259 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 85 | $178 |
| Tc99m sestamibi | 137 | $175 |
| Injection, regadenoson, 0.1 mg | 92 | $51 |
2019
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 571 | $3,415 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 277 | $2,321 |
| Myocardial perfusion imaging, tomographic (SPECT) (including attenuation correction, qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional quantification, when performed); multiple studies, at rest and/or stress (exercise or pharmacologic) and/or redistribution and/or rest reinjection | 72 | $1,017 |
| Return visit (30+ min) | 200 | $1,011 |
| CARDIOVASCULAR STRESS TEST | 139 | $780 |
| Tc99m sestamibi | 99 | $613 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 29 | $536 |
| Injection, regadenoson, 0.1 mg | 78 | $237 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 156 | $169 |
| Programming device evaluation (in person) with iterative adjustment of the implantable device to test the function of the device and select optimal permanent programmed values with analysis, review and report by a physician or other qualified health care professional; dual lead pacemaker system | 26 | $0 |
2018
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 368 | $4,446 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 1,089 | $4,077 |
| Myocardial perfusion imaging, tomographic (SPECT) (including attenuation correction, qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional quantification, when performed); multiple studies, at rest and/or stress (exercise or pharmacologic) and/or redistribution and/or rest reinjection | 159 | $3,295 |
| CARDIOVASCULAR STRESS TEST | 224 | $1,650 |
| Tc99m sestamibi | 165 | $1,523 |
| Injection, regadenoson, 0.1 mg | 136 | $1,486 |
| Return visit (30+ min) | 291 | $1,368 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 184 | $472 |
| Injection procedure during cardiac catheterization including imaging supervision, interpretation, and report; for supravalvular aortography (List separately in addition to code for primary procedure) | 15 | $252 |
| Short return visit (20+ min) | 55 | $238 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intraservice time, patient age 5 years or older | 44 | $192 |
| Programming device evaluation (in person) with iterative adjustment of the implantable device to test the function of the device and select optimal permanent programmed values with analysis, review and report by a physician or other qualified health care professional; dual lead pacemaker system | 27 | $70 |
Drugs they prescribed that Part D paid
$1,639,773
Pharmacies billed $1,639,773 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 11,278) in 2024. At or below the middle of the specialty; the typical interventional cardiology clinician is at 0%.
9,969 generic and 1,309 brand-name prescriptions · $1,639,773 in drug cost · 87 antibiotic prescriptions to 78 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 439 | $594,611 | $1,354 |
| Xarelto | 91 | $133,359 | $1,465 |
| Ambrisentan | 19 | $131,907 | $6,942 |
| Entresto | 78 | $126,690 | $1,624 |
| Repatha Sureclick | 142 | $117,589 | $828 |
See all 82 drugs
| Eliquis | 439 | $594,611 | $1,354 |
| Xarelto | 91 | $133,359 | $1,465 |
| Ambrisentan | 19 | $131,907 | $6,942 |
| Entresto | 78 | $126,690 | $1,624 |
| Repatha Sureclick | 142 | $117,589 | $828 |
| Jardiance | 57 | $58,417 | $1,025 |
| Farxiga | 39 | $44,512 | $1,141 |
| Vascepa | 56 | $42,879 | $766 |
| Tadalafil | 11 | $32,462 | $2,951 |
| Metoprolol | 1,670 | $30,496 | $18 |
| Brilinta | 33 | $29,472 | $893 |
| Ezetimibe | 551 | $17,735 | $32 |
| Praluent | 23 | $15,529 | $675 |
| Rosuvastatin | 525 | $11,240 | $21 |
| Potassium Chloride | 343 | $10,282 | $30 |
| Olmesartan Medoxomil | 330 | $8,443 | $26 |
| Amiodarone | 240 | $7,998 | $33 |
| Atorvastatin | 694 | $7,710 | $11 |
| Clopidogrel | 576 | $7,259 | $13 |
| Olmesartan-Hydrochlorothiazide | 113 | $6,811 | $60 |
| Losartan | 553 | $6,674 | $12 |
| Icosapent Ethyl | 20 | $6,578 | $329 |
| Edarbi | 12 | $5,937 | $495 |
| Dabigatran Etexilate | 15 | $5,932 | $395 |
| Amlodipine Besylate | 670 | $4,960 | $7 |
| Valsartan | 121 | $4,845 | $40 |
| Pradaxa | 14 | $4,748 | $339 |
| Pitavastatin | 21 | $4,353 | $207 |
| Carvedilol | 375 | $3,990 | $11 |
| Midodrine | 43 | $3,866 | $90 |
| Furosemide | 424 | $3,258 | $8 |
| Dilt-Xr | 56 | $2,852 | $51 |
| Diltiazem 24hr Er (La) | 18 | $2,846 | $158 |
| Atenolol | 294 | $2,803 | $10 |
| Ranolazine Er | 14 | $2,683 | $192 |
| Lisinopril | 247 | $2,512 | $10 |
| Diltiazem 24hr Er (Cd) | 47 | $2,425 | $52 |
| Eplerenone | 25 | $2,238 | $90 |
| Diltiazem 24hr Er (Xr) | 48 | $2,233 | $47 |
| Nebivolol | 40 | $2,143 | $54 |
| Flecainide Acetate | 45 | $2,124 | $47 |
| Niacin Er | 23 | $2,002 | $87 |
| Bumetanide | 32 | $1,832 | $57 |
| Metolazone | 29 | $1,805 | $62 |
| Triamterene-Hydrochlorothiazid | 150 | $1,764 | $12 |
| Klor-Con 10 | 64 | $1,710 | $27 |
| Pantoprazole | 101 | $1,566 | $16 |
| Nitroglycerin | 91 | $1,372 | $15 |
| Diltiazem 24hr Er | 36 | $1,368 | $38 |
| Valsartan-Hydrochlorothiazide | 52 | $1,313 | $25 |
| Spironolactone | 120 | $1,279 | $11 |
| Hydralazine | 91 | $1,242 | $14 |
| Pravastatin | 69 | $1,192 | $17 |
| Isosorbide Mononitrate Er | 63 | $1,135 | $18 |
| Pindolol | 14 | $1,028 | $73 |
| Cilostazol | 25 | $907 | $36 |
| Fenofibrate | 26 | $902 | $35 |
| Fenofibrate | 21 | $886 | $42 |
| Telmisartan | 39 | $857 | $22 |
| Warfarin | 67 | $811 | $12 |
| Losartan-Hydrochlorothiazide | 55 | $785 | $14 |
| Clonidine | 87 | $778 | $9 |
| Metoprolol | 64 | $683 | $11 |
| Ramipril | 37 | $635 | $17 |
| Propafenone | 13 | $613 | $47 |
| Diltiazem | 34 | $607 | $18 |
| Amlodipine Besylate-Benazepril | 21 | $540 | $26 |
| Nifedipine Er | 15 | $437 | $29 |
| Levothyroxine | 25 | $369 | $15 |
| Fludrocortisone Acetate | 11 | $368 | $33 |
| Famotidine | 21 | $368 | $18 |
| Hydrochlorothiazide | 102 | $361 | $4 |
| Omeprazole | 23 | $341 | $15 |
| Benazepril | 34 | $322 | $9 |
| Chlorthalidone | 22 | $296 | $13 |
| Irbesartan | 31 | $295 | $10 |
| Lisinopril-Hydrochlorothiazide | 18 | $293 | $16 |
| Cephalexin | 66 | $293 | $4 |
| Simvastatin | 33 | $273 | $8 |
| Propranolol | 13 | $258 | $20 |
| Ropinirole | 16 | $198 | $12 |
| Allopurinol | 11 | $148 | $13 |
Year by year
| 2024 | 11,278 | 1,714 | 0% (0) | 12% | $1,639,773 |
| 2023 | 11,537 | 1,705 | None | 12% | $1,791,112 |
| 2022 | 12,041 | 1,705 | 0% (0) | 11% | $1,664,685 |
| 2021 | 11,113 | 1,529 | None | 12% | $1,572,159 |
| 2020 | 11,511 | 1,529 | 0% (0) | 14% | $1,860,606 |
| 2019 | 12,057 | 1,563 | None | None | $1,753,552 |
| 2018 | 11,374 | 1,478 | None | 15% | $1,711,586 |
| 2017 | 11,253 | 1,344 | None | None | $1,587,633 |
| 2016 | 12,631 | 1,356 | None | 21% | $1,516,049 |
| 2015 | 14,807 | 1,386 | None | None | $1,297,723 |
| 2014 | 15,835 | 1,410 | None | None | $1,139,572 |
| 2013 | 16,912 | 1,374 | 0% (13) | 25% | $1,006,377 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 79 drugs
| Eliquis | 454 | $633,682 | $1,396 |
| Ambrisentan | 45 | $165,425 | $3,676 |
| Xarelto | 122 | $152,078 | $1,247 |
| Entresto | 78 | $142,617 | $1,828 |
| Repatha Sureclick | 163 | $131,436 | $806 |
| Farxiga | 26 | $45,799 | $1,762 |
| Vascepa | 46 | $43,091 | $937 |
| Metoprolol | 1,676 | $40,494 | $24 |
| Brilinta | 36 | $29,829 | $829 |
| Ezetimibe | 524 | $28,732 | $55 |
| Icosapent Ethyl | 45 | $26,425 | $587 |
| Tadalafil | 12 | $17,122 | $1,427 |
| Amiodarone | 252 | $17,055 | $68 |
| Olmesartan Medoxomil | 347 | $16,743 | $48 |
| Praluent | 18 | $15,959 | $887 |
| Jardiance | 14 | $15,253 | $1,089 |
| Potassium Chloride | 361 | $15,121 | $42 |
| Rosuvastatin | 481 | $14,151 | $29 |
| Atorvastatin | 657 | $12,343 | $19 |
| Livalo | 14 | $12,168 | $869 |
| Olmesartan-Hydrochlorothiazide | 127 | $10,754 | $85 |
| Losartan | 552 | $10,603 | $19 |
| Clopidogrel | 488 | $9,567 | $20 |
| Valsartan | 118 | $8,806 | $75 |
| Amlodipine Besylate | 714 | $8,208 | $11 |
| Carvedilol | 378 | $6,477 | $17 |
| Edarbi | 14 | $5,571 | $398 |
| Flecainide Acetate | 59 | $4,870 | $83 |
| Atenolol | 327 | $4,742 | $15 |
| Midodrine | 51 | $4,741 | $93 |
| Lisinopril | 304 | $4,394 | $14 |
| Metolazone | 52 | $4,383 | $84 |
| Furosemide | 420 | $4,189 | $10 |
| Nebivolol | 41 | $3,717 | $91 |
| Diltiazem 24hr Er (Xr) | 64 | $3,678 | $57 |
| Triamterene-Hydrochlorothiazid | 191 | $3,625 | $19 |
| Diltiazem 24hr Er (Cd) | 48 | $3,317 | $69 |
| Dilt-Xr | 49 | $2,995 | $61 |
| Klor-Con 10 | 73 | $2,982 | $41 |
| Bumetanide | 36 | $2,892 | $80 |
| Diltiazem 24hr Er (La) | 18 | $2,891 | $161 |
| Diltiazem 24hr Er | 53 | $2,785 | $53 |
| Eplerenone | 23 | $2,140 | $93 |
| Hydralazine | 91 | $2,137 | $23 |
| Valsartan-Hydrochlorothiazide | 45 | $2,067 | $46 |
| Niacin Er | 26 | $2,048 | $79 |
| Isosorbide Mononitrate Er | 78 | $2,030 | $26 |
| Spironolactone | 117 | $2,010 | $17 |
| Pantoprazole | 102 | $1,993 | $20 |
| Diltiazem | 52 | $1,753 | $34 |
| Ramipril | 49 | $1,686 | $34 |
| Pravastatin | 95 | $1,661 | $17 |
| Fenofibrate | 28 | $1,659 | $59 |
| Telmisartan | 32 | $1,533 | $48 |
| Warfarin | 74 | $1,480 | $20 |
| Clonidine | 89 | $1,473 | $17 |
| Nitroglycerin | 79 | $1,397 | $18 |
| Losartan-Hydrochlorothiazide | 61 | $1,390 | $23 |
| Amlodipine Besylate-Benazepril | 21 | $1,062 | $51 |
| Benazepril | 60 | $1,016 | $17 |
| Fenofibric Acid | 11 | $788 | $72 |
| Fludrocortisone Acetate | 18 | $730 | $41 |
| Levothyroxine | 33 | $713 | $22 |
| Lisinopril-Hydrochlorothiazide | 32 | $702 | $22 |
| Metoprolol | 60 | $698 | $12 |
| Irbesartan | 41 | $639 | $16 |
| Fenofibrate | 14 | $624 | $45 |
| Hydrochlorothiazide | 118 | $603 | $5 |
| Cilostazol | 11 | $599 | $54 |
| Famotidine | 28 | $515 | $18 |
| Propranolol | 24 | $503 | $21 |
| Chlorthalidone | 25 | $493 | $20 |
| Simvastatin | 35 | $491 | $14 |
| Cephalexin | 47 | $421 | $9 |
| Sildenafil Citrate | 12 | $393 | $33 |
| Omeprazole | 23 | $378 | $16 |
| Ropinirole | 15 | $317 | $21 |
| Enalapril Maleate | 14 | $204 | $15 |
| Allopurinol | 18 | $160 | $9 |
2022: 84 drugs
| Eliquis | 447 | $558,549 | $1,250 |
| Ambrisentan | 44 | $186,576 | $4,240 |
| Xarelto | 111 | $138,640 | $1,249 |
| Repatha Sureclick | 161 | $126,466 | $786 |
| Entresto | 69 | $99,759 | $1,446 |
| Vascepa | 49 | $51,602 | $1,053 |
| Metoprolol | 1,734 | $39,867 | $23 |
| Brilinta | 40 | $37,247 | $931 |
| Ezetimibe | 473 | $35,937 | $76 |
| Pradaxa | 24 | $29,489 | $1,229 |
| Icosapent Ethyl | 41 | $21,987 | $536 |
| Rosuvastatin | 449 | $19,952 | $44 |
| Farxiga | 13 | $19,333 | $1,487 |
| Amiodarone | 308 | $18,191 | $59 |
| Potassium Chloride | 406 | $15,186 | $37 |
| Praluent | 15 | $13,556 | $904 |
| Olmesartan Medoxomil | 354 | $12,922 | $37 |
| Olmesartan-Hydrochlorothiazide | 152 | $12,024 | $79 |
| Atorvastatin | 623 | $10,039 | $16 |
| Valsartan | 135 | $9,845 | $73 |
| Clopidogrel | 486 | $9,125 | $19 |
| Losartan | 606 | $8,782 | $14 |
| Midodrine | 61 | $8,611 | $141 |
| Carvedilol | 441 | $6,968 | $16 |
| Amlodipine Besylate | 773 | $6,369 | $8 |
| Metolazone | 55 | $5,757 | $105 |
| Eplerenone | 28 | $5,123 | $183 |
| Diltiazem 24hr Er (Cd) | 86 | $4,537 | $53 |
| Flecainide Acetate | 62 | $4,413 | $71 |
| Tadalafil | 11 | $4,384 | $399 |
| Diltiazem 24hr Er (Xr) | 72 | $4,197 | $58 |
| Furosemide | 442 | $3,732 | $8 |
| Triamterene-Hydrochlorothiazid | 205 | $3,576 | $17 |
| Valsartan-Hydrochlorothiazide | 60 | $3,510 | $58 |
| Diltiazem 24hr Er | 79 | $3,409 | $43 |
| Dilt-Xr | 63 | $3,248 | $52 |
| Hydralazine | 126 | $3,118 | $25 |
| Lisinopril | 343 | $3,030 | $9 |
| Isosorbide Mononitrate Er | 92 | $2,773 | $30 |
| Nebivolol | 46 | $2,763 | $60 |
| Fenofibrate | 28 | $2,692 | $96 |
| Bumetanide | 30 | $2,678 | $89 |
| Atenolol | 279 | $2,626 | $9 |
| Propafenone Hcl Er | 15 | $2,615 | $174 |
| Niacin Er | 27 | $2,119 | $78 |
| Pantoprazole | 97 | $1,857 | $19 |
| Pravastatin | 92 | $1,727 | $19 |
| Klor-Con 10 | 55 | $1,711 | $31 |
| Telmisartan | 18 | $1,696 | $94 |
| Losartan-Hydrochlorothiazide | 80 | $1,663 | $21 |
| Clonidine | 116 | $1,649 | $14 |
| Warfarin | 87 | $1,521 | $17 |
| Diltiazem | 46 | $1,483 | $32 |
| Nitroglycerin | 90 | $1,329 | $15 |
| Fenofibric Acid | 11 | $1,065 | $97 |
| Sotalol | 15 | $974 | $65 |
| Sildenafil Citrate | 23 | $971 | $42 |
| Levothyroxine | 37 | $956 | $26 |
| Irbesartan | 41 | $941 | $23 |
| Benazepril | 67 | $933 | $14 |
| Fenofibrate | 14 | $902 | $64 |
| Spironolactone | 94 | $882 | $9 |
| Ramipril | 27 | $878 | $33 |
| Hydrochlorothiazide | 142 | $820 | $6 |
| Fludrocortisone Acetate | 18 | $780 | $43 |
| Nifedipine Er | 12 | $697 | $58 |
| Omeprazole | 32 | $639 | $20 |
| Amlodipine Besylate-Benazepril | 20 | $616 | $31 |
| Metoprolol | 74 | $593 | $8 |
| Propranolol | 13 | $560 | $43 |
| Benazepril-Hydrochlorothiazide | 11 | $554 | $50 |
| Labetalol | 13 | $525 | $40 |
| Ropinirole | 25 | $491 | $20 |
| Famotidine | 32 | $393 | $12 |
| Irbesartan-Hydrochlorothiazide | 13 | $350 | $27 |
| Tiadylt Er | 11 | $323 | $29 |
| Chlorthalidone | 11 | $312 | $28 |
| Simvastatin | 37 | $267 | $7 |
| Cephalexin | 38 | $263 | $7 |
| Lisinopril-Hydrochlorothiazide | 29 | $246 | $8 |
| Gabapentin | 19 | $227 | $12 |
| Allopurinol | 14 | $146 | $10 |
| Meclizine | 13 | $91 | $7 |
| Lovastatin | 11 | $88 | $8 |
2021: 79 drugs
| Eliquis | 408 | $469,972 | $1,152 |
| Ambrisentan | 51 | $268,419 | $5,263 |
| Xarelto | 74 | $87,086 | $1,177 |
| Entresto | 54 | $81,199 | $1,504 |
| Repatha Sureclick | 137 | $80,559 | $588 |
| Vascepa | 81 | $74,483 | $920 |
| Metoprolol | 1,492 | $39,846 | $27 |
| Brilinta | 36 | $34,759 | $966 |
| Ezetimibe | 365 | $32,786 | $90 |
| Pradaxa | 31 | $30,331 | $978 |
| Rosuvastatin | 412 | $22,262 | $54 |
| Bystolic | 45 | $18,485 | $411 |
| Potassium Chloride | 405 | $17,715 | $44 |
| Livalo | 24 | $15,910 | $663 |
| Olmesartan Medoxomil | 305 | $15,533 | $51 |
| Amiodarone | 239 | $12,149 | $51 |
| Atorvastatin | 639 | $11,380 | $18 |
| Valsartan | 137 | $10,468 | $76 |
| Losartan | 562 | $9,005 | $16 |
| Clopidogrel | 507 | $8,389 | $17 |
| Midodrine | 75 | $8,340 | $111 |
| Praluent | 11 | $7,814 | $710 |
| Carvedilol | 437 | $7,329 | $17 |
| Olmesartan-Hydrochlorothiazide | 116 | $7,314 | $63 |
| Metolazone | 62 | $6,819 | $110 |
| Dilt-Xr | 107 | $6,534 | $61 |
| Eplerenone | 36 | $6,332 | $176 |
| Amlodipine Besylate | 690 | $6,229 | $9 |
| Diltiazem 24hr Er | 98 | $5,780 | $59 |
| Pacerone | 28 | $5,274 | $188 |
| Diltiazem 24hr Er (Cd) | 84 | $5,073 | $60 |
| Niacin Er | 36 | $4,999 | $139 |
| Flecainide Acetate | 71 | $4,905 | $69 |
| Tadalafil | 11 | $4,386 | $399 |
| Furosemide | 463 | $3,391 | $7 |
| Valsartan-Hydrochlorothiazide | 55 | $3,036 | $55 |
| Isosorbide Mononitrate Er | 92 | $2,966 | $32 |
| Lisinopril | 284 | $2,907 | $10 |
| Triamterene-Hydrochlorothiazid | 177 | $2,844 | $16 |
| Hydralazine | 98 | $2,595 | $26 |
| Fenofibrate | 25 | $2,488 | $100 |
| Losartan-Hydrochlorothiazide | 72 | $2,408 | $33 |
| Diltiazem 24hr Er (Xr) | 31 | $2,301 | $74 |
| Atenolol | 221 | $1,988 | $9 |
| Bumetanide | 22 | $1,963 | $89 |
| Irbesartan | 49 | $1,867 | $38 |
| Warfarin | 95 | $1,849 | $19 |
| Fludrocortisone Acetate | 33 | $1,568 | $48 |
| Pravastatin | 86 | $1,539 | $18 |
| Nitroglycerin | 88 | $1,538 | $17 |
| Klor-Con 10 | 43 | $1,438 | $33 |
| Pantoprazole | 65 | $1,425 | $22 |
| Propafenone | 19 | $1,254 | $66 |
| Diltiazem | 39 | $1,254 | $32 |
| Fenofibrate | 19 | $1,234 | $65 |
| Benazepril-Hydrochlorothiazide | 11 | $1,038 | $94 |
| Spironolactone | 83 | $1,009 | $12 |
| Clonidine | 100 | $940 | $9 |
| Hydrochlorothiazide | 136 | $901 | $7 |
| Benazepril | 66 | $869 | $13 |
| Nifedipine Er | 18 | $866 | $48 |
| Cilostazol | 22 | $803 | $36 |
| Omeprazole | 40 | $792 | $20 |
| Sildenafil Citrate | 21 | $722 | $34 |
| Metoprolol | 72 | $720 | $10 |
| Levothyroxine | 22 | $617 | $28 |
| Sotalol | 13 | $611 | $47 |
| Amlodipine Besylate-Benazepril | 12 | $523 | $44 |
| Klor-Con 8 | 13 | $481 | $37 |
| Labetalol | 15 | $474 | $32 |
| Irbesartan-Hydrochlorothiazide | 12 | $454 | $38 |
| Famotidine | 25 | $387 | $15 |
| Lisinopril-Hydrochlorothiazide | 45 | $347 | $8 |
| Ropinirole | 23 | $338 | $15 |
| Gabapentin | 19 | $292 | $15 |
| Allopurinol | 14 | $217 | $15 |
| Simvastatin | 36 | $207 | $6 |
| Meclizine | 13 | $191 | $15 |
| Cephalexin | 27 | $84 | $3 |
2020: 82 drugs
| Eliquis | 395 | $426,794 | $1,080 |
| Ambrisentan | 60 | $332,239 | $5,537 |
| Xarelto | 111 | $117,211 | $1,056 |
| Entresto | 57 | $71,761 | $1,259 |
| Repatha Sureclick | 126 | $67,756 | $538 |
| Vascepa | 76 | $54,344 | $715 |
| Northera | 12 | $47,922 | $3,994 |
| Brilinta | 53 | $46,683 | $881 |
| Pradaxa | 57 | $44,185 | $775 |
| Metoprolol | 1,423 | $42,201 | $30 |
| Ezetimibe | 389 | $32,017 | $82 |
| Bystolic | 64 | $25,276 | $395 |
| Rosuvastatin | 347 | $21,050 | $61 |
| Olmesartan Medoxomil | 266 | $17,608 | $66 |
| Potassium Chloride | 385 | $16,790 | $44 |
| Amiodarone | 222 | $14,454 | $65 |
| Atorvastatin | 700 | $13,629 | $19 |
| Midodrine | 76 | $11,914 | $157 |
| Pacerone | 34 | $10,278 | $302 |
| Losartan | 610 | $9,614 | $16 |
| Valsartan | 114 | $9,608 | $84 |
| Clopidogrel | 551 | $9,355 | $17 |
| Dilt-Xr | 159 | $8,943 | $56 |
| Eplerenone | 50 | $8,735 | $175 |
| Diltiazem 24hr Er | 133 | $8,492 | $64 |
| Livalo | 18 | $7,766 | $431 |
| Niacin Er | 38 | $7,019 | $185 |
| Olmesartan-Hydrochlorothiazide | 107 | $6,833 | $64 |
| Diltiazem 24hr Er (Cd) | 111 | $6,644 | $60 |
| Carvedilol | 471 | $5,928 | $13 |
| Amlodipine Besylate | 812 | $5,869 | $7 |
| Flecainide Acetate | 71 | $5,628 | $79 |
| Tadalafil | 12 | $4,786 | $399 |
| Metolazone | 60 | $4,779 | $80 |
| Losartan-Hydrochlorothiazide | 73 | $4,118 | $56 |
| Valsartan-Hydrochlorothiazide | 51 | $3,723 | $73 |
| Lisinopril | 331 | $3,642 | $11 |
| Triamterene-Hydrochlorothiazid | 192 | $3,446 | $18 |
| Furosemide | 451 | $3,269 | $7 |
| Isosorbide Mononitrate Er | 90 | $2,975 | $33 |
| Fenofibric Acid | 14 | $2,833 | $202 |
| Hydralazine | 97 | $2,778 | $29 |
| Bumetanide | 34 | $2,730 | $80 |
| Candesartan Cilexetil | 15 | $2,725 | $182 |
| Warfarin | 138 | $2,559 | $19 |
| Cartia Xt | 46 | $2,505 | $54 |
| Fenofibrate | 25 | $2,355 | $94 |
| Pravastatin | 87 | $2,192 | $25 |
| Irbesartan | 54 | $2,093 | $39 |
| Fenofibrate | 28 | $1,972 | $70 |
| Atenolol | 172 | $1,811 | $11 |
| Diltiazem | 47 | $1,750 | $37 |
| Nitroglycerin | 105 | $1,663 | $16 |
| Ranolazine Er | 11 | $1,346 | $122 |
| Benazepril-Hydrochlorothiazide | 14 | $1,176 | $84 |
| Hydrochlorothiazide | 161 | $1,117 | $7 |
| Cilostazol | 24 | $1,112 | $46 |
| Telmisartan | 11 | $1,107 | $101 |
| Amlodipine Besylate-Benazepril | 24 | $1,106 | $46 |
| Fludrocortisone Acetate | 25 | $1,003 | $40 |
| Propafenone | 26 | $985 | $38 |
| Metoprolol | 94 | $969 | $10 |
| Levothyroxine | 32 | $958 | $30 |
| Klor-Con 10 | 30 | $885 | $30 |
| Nifedipine Er | 18 | $849 | $47 |
| Pantoprazole | 52 | $839 | $16 |
| Spironolactone | 70 | $729 | $10 |
| Propranolol | 12 | $725 | $60 |
| Sotalol | 11 | $701 | $64 |
| Pindolol | 17 | $678 | $40 |
| Omeprazole | 41 | $670 | $16 |
| Clonidine | 75 | $628 | $8 |
| Benazepril | 60 | $587 | $10 |
| Sildenafil Citrate | 12 | $402 | $34 |
| Irbesartan-Hydrochlorothiazide | 18 | $382 | $21 |
| Meclizine | 15 | $335 | $22 |
| Lisinopril-Hydrochlorothiazide | 47 | $319 | $7 |
| Famotidine | 17 | $290 | $17 |
| Allopurinol | 13 | $254 | $20 |
| Simvastatin | 31 | $194 | $6 |
| Gabapentin | 16 | $150 | $9 |
| Cephalexin | 35 | $105 | $3 |
2019: 85 drugs
| Letairis | 36 | $341,984 | $9,500 |
| Eliquis | 332 | $328,659 | $990 |
| Ambrisentan | 31 | $132,223 | $4,265 |
| Xarelto | 109 | $102,239 | $938 |
| Repatha Sureclick | 102 | $75,259 | $738 |
| Entresto | 44 | $58,693 | $1,334 |
| Metoprolol | 1,322 | $48,805 | $37 |
| Pradaxa | 60 | $46,564 | $776 |
| Vascepa | 71 | $43,368 | $611 |
| Brilinta | 52 | $34,227 | $658 |
| Ezetimibe | 331 | $31,103 | $94 |
| Bystolic | 72 | $22,313 | $310 |
| Rosuvastatin | 300 | $21,289 | $71 |
| Amiodarone | 243 | $20,053 | $83 |
| Atorvastatin | 859 | $18,359 | $21 |
| Potassium Chloride | 415 | $18,228 | $44 |
| Olmesartan Medoxomil | 184 | $13,524 | $74 |
| Midodrine | 96 | $13,358 | $139 |
| Niacin Er | 50 | $11,045 | $221 |
| Tadalafil | 12 | $10,820 | $902 |
| Dilt-Xr | 192 | $10,750 | $56 |
| Livalo | 23 | $10,332 | $449 |
| Clopidogrel | 570 | $10,252 | $18 |
| Crestor | 13 | $9,570 | $736 |
| Losartan | 637 | $9,058 | $14 |
| Sildenafil Citrate | 11 | $9,017 | $820 |
| Carvedilol | 674 | $8,872 | $13 |
| Valsartan | 114 | $8,403 | $74 |
| Diltiazem 24hr Er (Cd) | 122 | $8,059 | $66 |
| Ranolazine Er | 20 | $7,546 | $377 |
| Olmesartan-Hydrochlorothiazide | 82 | $7,425 | $91 |
| Amlodipine Besylate | 768 | $6,304 | $8 |
| Pacerone | 15 | $6,214 | $414 |
| Eplerenone | 32 | $6,148 | $192 |
| Diltiazem 24hr Er | 106 | $5,995 | $57 |
| Lisinopril | 402 | $4,631 | $12 |
| Triamterene-Hydrochlorothiazid | 248 | $4,553 | $18 |
| Isosorbide Mononitrate Er | 119 | $3,768 | $32 |
| Flecainide Acetate | 60 | $3,696 | $62 |
| Fenofibric Acid | 16 | $3,525 | $220 |
| Warfarin | 190 | $3,218 | $17 |
| Fenofibrate | 27 | $3,169 | $117 |
| Valsartan-Hydrochlorothiazide | 55 | $3,149 | $57 |
| Hydralazine | 126 | $3,144 | $25 |
| Furosemide | 453 | $3,116 | $7 |
| Bumetanide | 38 | $3,057 | $80 |
| Candesartan Cilexetil | 23 | $2,926 | $127 |
| Pravastatin | 90 | $2,746 | $31 |
| Fenofibrate | 37 | $2,713 | $73 |
| Diltiazem 12hr Er | 11 | $2,276 | $207 |
| Atenolol | 193 | $2,250 | $12 |
| Losartan-Hydrochlorothiazide | 128 | $2,232 | $17 |
| Diltiazem | 46 | $2,124 | $46 |
| Metolazone | 22 | $2,067 | $94 |
| Nitroglycerin | 96 | $1,936 | $20 |
| Ranitidine | 50 | $1,928 | $39 |
| Irbesartan | 55 | $1,893 | $34 |
| Cartia Xt | 54 | $1,682 | $31 |
| Omega-3 Acid Ethyl Esters | 17 | $1,569 | $92 |
| Propafenone | 28 | $1,517 | $54 |
| Pantoprazole | 99 | $1,469 | $15 |
| Toprol Xl | 16 | $1,372 | $86 |
| Cilostazol | 48 | $1,302 | $27 |
| Propranolol | 12 | $1,301 | $108 |
| Amlodipine Besylate-Benazepril | 25 | $1,254 | $50 |
| Verapamil Sr | 11 | $1,168 | $106 |
| Klor-Con 10 | 25 | $1,158 | $46 |
| Clonidine | 94 | $1,004 | $11 |
| Benazepril | 83 | $981 | $12 |
| Metoprolol | 104 | $927 | $9 |
| Levothyroxine | 34 | $925 | $27 |
| Spironolactone | 86 | $853 | $10 |
| Fludrocortisone Acetate | 22 | $782 | $36 |
| Omeprazole | 44 | $752 | $17 |
| Hydrochlorothiazide | 116 | $617 | $5 |
| Meclizine | 24 | $513 | $21 |
| Nifedipine Er | 13 | $509 | $39 |
| Irbesartan-Hydrochlorothiazide | 15 | $480 | $32 |
| Sotalol | 12 | $417 | $35 |
| Simvastatin | 39 | $322 | $8 |
| Lisinopril-Hydrochlorothiazide | 51 | $304 | $6 |
| Gabapentin | 15 | $235 | $16 |
| Famotidine | 13 | $140 | $11 |
| Cephalexin | 17 | $93 | $5 |
| Lovastatin | 13 | $81 | $6 |
2018: 87 drugs
| Letairis | 54 | $677,048 | $12,538 |
| Eliquis | 236 | $222,049 | $941 |
| Xarelto | 84 | $72,665 | $865 |
| Repatha Sureclick | 38 | $68,373 | $1,799 |
| Entresto | 54 | $47,856 | $886 |
| Metoprolol | 1,080 | $44,690 | $41 |
| Brilinta | 56 | $43,758 | $781 |
| Pradaxa | 49 | $36,656 | $748 |
| Ranexa | 37 | $35,250 | $953 |
| Ezetimibe | 175 | $21,209 | $121 |
| Atorvastatin | 884 | $19,554 | $22 |
| Potassium Chloride | 374 | $19,385 | $52 |
| Vascepa | 28 | $18,958 | $677 |
| Bystolic | 66 | $18,780 | $285 |
| Amiodarone | 235 | $15,742 | $67 |
| Rosuvastatin | 240 | $13,919 | $58 |
| Niacin Er | 46 | $11,499 | $250 |
| Valsartan | 188 | $11,020 | $59 |
| Midodrine | 72 | $10,838 | $151 |
| Diltiazem 24hr Er (Cd) | 168 | $9,017 | $54 |
| Losartan | 701 | $8,564 | $12 |
| Crestor | 13 | $8,546 | $657 |
| Clopidogrel | 555 | $8,430 | $15 |
| Carvedilol | 722 | $8,059 | $11 |
| Olmesartan Medoxomil | 109 | $7,612 | $70 |
| Amlodipine Besylate | 707 | $6,478 | $9 |
| Dilt-Xr | 112 | $5,458 | $49 |
| Olmesartan-Hydrochlorothiazide | 38 | $4,805 | $126 |
| Omega-3 Acid Ethyl Esters | 38 | $4,516 | $119 |
| Diltiazem 24hr Er | 96 | $4,245 | $44 |
| Triamterene-Hydrochlorothiazid | 250 | $4,217 | $17 |
| Isosorbide Mononitrate Er | 113 | $3,996 | $35 |
| Carvedilol Er | 12 | $3,902 | $325 |
| Fenofibrate | 47 | $3,883 | $83 |
| Lisinopril | 337 | $3,830 | $11 |
| Bumetanide | 31 | $3,752 | $121 |
| Fenofibric Acid | 17 | $3,453 | $203 |
| Valsartan-Hydrochlorothiazide | 82 | $3,359 | $41 |
| Pravastatin | 97 | $3,318 | $34 |
| Flecainide Acetate | 47 | $3,286 | $70 |
| Diltiazem 12hr Er | 17 | $3,178 | $187 |
| Warfarin | 184 | $2,987 | $16 |
| Furosemide | 466 | $2,788 | $6 |
| Cilostazol | 77 | $2,710 | $35 |
| Fenofibrate | 23 | $2,442 | $106 |
| Hydralazine | 108 | $2,404 | $22 |
| Nitroglycerin | 106 | $2,296 | $22 |
| Losartan-Hydrochlorothiazide | 132 | $2,266 | $17 |
| Edarbi | 11 | $2,133 | $194 |
| Cartia Xt | 72 | $2,106 | $29 |
| Atenolol | 184 | $1,993 | $11 |
| Verapamil Sr | 16 | $1,936 | $121 |
| Candesartan Cilexetil | 12 | $1,909 | $159 |
| Amlodipine Besylate-Benazepril | 43 | $1,675 | $39 |
| Toprol Xl | 20 | $1,631 | $82 |
| Metolazone | 16 | $1,455 | $91 |
| Klor-Con 8 | 36 | $1,336 | $37 |
| Levothyroxine | 45 | $1,321 | $29 |
| Benazepril | 117 | $1,292 | $11 |
| Metoprolol | 104 | $1,233 | $12 |
| Diltiazem | 35 | $1,214 | $35 |
| Propafenone | 22 | $1,214 | $55 |
| Pantoprazole | 79 | $1,207 | $15 |
| Propranolol | 20 | $1,192 | $60 |
| Omeprazole | 64 | $1,190 | $19 |
| Ranitidine | 72 | $1,147 | $16 |
| Spironolactone | 91 | $1,099 | $12 |
| Irbesartan | 45 | $1,084 | $24 |
| Klor-Con 10 | 23 | $997 | $43 |
| Clonidine | 92 | $929 | $10 |
| Fludrocortisone Acetate | 21 | $624 | $30 |
| Digoxin | 13 | $610 | $47 |
| Nifedipine Er | 16 | $595 | $37 |
| Diltiazem 24hr Er (Xr) | 12 | $496 | $41 |
| Simvastatin | 47 | $445 | $9 |
| Klor-Con Sprinkle | 14 | $396 | $28 |
| Hydrochlorothiazide | 77 | $370 | $5 |
| Meclizine | 13 | $316 | $24 |
| Gabapentin | 12 | $279 | $23 |
| Ropinirole | 16 | $100 | $6 |
| Lisinopril-Hydrochlorothiazide | 27 | $90 | $3 |
| Zolpidem | 11 | $72 | $7 |
| Prednisone | 14 | $69 | $5 |
| Lovastatin | 13 | $66 | $5 |
| Famotidine | 12 | $57 | $5 |
| Cephalexin | 19 | $47 | $2 |
| Naproxen | 11 | $26 | $2 |
2017: 88 drugs
| Letairis | 61 | $640,650 | $10,502 |
| Eliquis | 237 | $171,281 | $723 |
| Xarelto | 79 | $64,646 | $818 |
| Adcirca | 16 | $60,870 | $3,804 |
| Ranexa | 52 | $46,416 | $893 |
| Metoprolol | 1,005 | $39,092 | $39 |
| Pradaxa | 48 | $35,614 | $742 |
| Repatha Sureclick | 17 | $26,053 | $1,533 |
| Brilinta | 39 | $25,247 | $647 |
| Ezetimibe | 99 | $23,257 | $235 |
| Zetia | 33 | $22,180 | $672 |
| Sildenafil | 14 | $19,899 | $1,421 |
| Atorvastatin | 918 | $19,567 | $21 |
| Entresto | 18 | $18,984 | $1,055 |
| Rosuvastatin | 176 | $15,603 | $89 |
| Amiodarone | 307 | $15,391 | $50 |
| Bystolic | 76 | $15,108 | $199 |
| Potassium Chloride | 310 | $14,797 | $48 |
| Niacin Er | 67 | $14,765 | $220 |
| Olmesartan Medoxomil | 80 | $12,346 | $154 |
| Coreg Cr | 25 | $12,306 | $492 |
| Effient | 16 | $11,084 | $693 |
| Valsartan | 166 | $9,931 | $60 |
| Diltiazem 24hr Er | 249 | $9,683 | $39 |
| Crestor | 14 | $8,920 | $637 |
| Clopidogrel | 534 | $7,890 | $15 |
| Losartan | 681 | $6,894 | $10 |
| Carvedilol | 694 | $6,642 | $10 |
| Midodrine | 43 | $6,446 | $150 |
| Omega-3 Acid Ethyl Esters | 42 | $6,356 | $151 |
| Flecainide Acetate | 62 | $5,343 | $86 |
| Vascepa | 11 | $5,223 | $475 |
| Olmesartan-Hydrochlorothiazide | 21 | $4,671 | $222 |
| Amlodipine Besylate | 751 | $4,649 | $6 |
| Isosorbide Mononitrate Er | 133 | $4,412 | $33 |
| Fenofibrate | 29 | $4,322 | $149 |
| Fenofibric Acid | 28 | $3,998 | $143 |
| Fenofibrate | 56 | $3,573 | $64 |
| Triamterene-Hydrochlorothiazid | 212 | $3,559 | $17 |
| Lisinopril | 357 | $3,544 | $10 |
| Warfarin | 217 | $3,411 | $16 |
| Pravastatin | 103 | $3,385 | $33 |
| Edarbi | 12 | $3,157 | $263 |
| Hydralazine | 111 | $3,036 | $27 |
| Diltiazem 24hr Cd | 17 | $2,971 | $175 |
| Dilt-Xr | 57 | $2,933 | $51 |
| Cilostazol | 68 | $2,925 | $43 |
| Valsartan-Hydrochlorothiazide | 41 | $2,847 | $69 |
| Klor-Con 8 | 77 | $2,783 | $36 |
| Cartia Xt | 66 | $2,650 | $40 |
| Furosemide | 474 | $2,435 | $5 |
| Mexiletine | 11 | $2,380 | $216 |
| Propafenone | 28 | $2,351 | $84 |
| Metolazone | 38 | $2,347 | $62 |
| Bumetanide | 24 | $2,133 | $89 |
| Toprol Xl | 28 | $2,109 | $75 |
| Nitroglycerin | 85 | $1,915 | $23 |
| Levothyroxine | 84 | $1,905 | $23 |
| Atenolol | 261 | $1,901 | $7 |
| Amlodipine Besylate-Benazepril | 52 | $1,898 | $36 |
| Losartan-Hydrochlorothiazide | 110 | $1,575 | $14 |
| Pantoprazole | 99 | $1,507 | $15 |
| Diltiazem | 44 | $1,436 | $33 |
| Klor-Con 10 | 20 | $1,261 | $63 |
| Metoprolol | 131 | $1,126 | $9 |
| Spironolactone | 93 | $1,106 | $12 |
| Benazepril | 125 | $1,105 | $9 |
| Omeprazole | 70 | $1,018 | $15 |
| Klor-Con Sprinkle | 26 | $1,005 | $39 |
| Nifedipine Er | 22 | $936 | $43 |
| Ranitidine | 67 | $808 | $12 |
| Propranolol | 14 | $803 | $57 |
| Simvastatin | 90 | $668 | $7 |
| Clonidine | 81 | $666 | $8 |
| Felodipine Er | 13 | $626 | $48 |
| Digox | 11 | $582 | $53 |
| Sotalol | 18 | $450 | $25 |
| Isosorbide Dinitrate | 11 | $422 | $38 |
| Meclizine | 17 | $378 | $22 |
| Lisinopril-Hydrochlorothiazide | 41 | $279 | $7 |
| Hydrochlorothiazide | 55 | $200 | $4 |
| Ramipril | 12 | $171 | $14 |
| Ropinirole | 21 | $136 | $6 |
| Trandolapril | 11 | $127 | $12 |
| Gabapentin | 13 | $88 | $7 |
| Lovastatin | 14 | $77 | $5 |
| Cephalexin | 21 | $71 | $3 |
| Naproxen | 17 | $41 | $2 |
2016: 90 drugs
| Letairis | 71 | $637,892 | $8,984 |
| Eliquis | 284 | $145,418 | $512 |
| Xarelto | 94 | $61,312 | $652 |
| Crestor | 133 | $58,082 | $437 |
| Zetia | 115 | $54,144 | $471 |
| Ranexa | 57 | $41,748 | $732 |
| Pradaxa | 47 | $37,990 | $808 |
| Metoprolol | 1,050 | $34,193 | $33 |
| Sildenafil | 23 | $25,788 | $1,121 |
| Atorvastatin | 1,096 | $21,864 | $20 |
| Praluent | 12 | $19,242 | $1,603 |
| Welchol | 13 | $18,848 | $1,450 |
| Effient | 33 | $18,460 | $559 |
| Niacin Er | 89 | $17,471 | $196 |
| Amiodarone | 385 | $16,273 | $42 |
| Potassium Chloride | 365 | $15,390 | $42 |
| Benicar | 31 | $14,075 | $454 |
| Coreg Cr | 26 | $13,764 | $529 |
| Brilinta | 24 | $12,510 | $521 |
| Valsartan | 115 | $12,261 | $107 |
| Bystolic | 63 | $10,793 | $171 |
| Clopidogrel | 569 | $9,052 | $16 |
| Rosuvastatin | 52 | $9,042 | $174 |
| Diltiazem 24hr Er | 226 | $8,595 | $38 |
| Losartan | 726 | $7,657 | $11 |
| Carvedilol | 710 | $7,461 | $11 |
| Amlodipine Besylate | 1,031 | $7,158 | $7 |
| Omega-3 Acid Ethyl Esters | 54 | $6,424 | $119 |
| Fenofibric Acid | 30 | $5,427 | $181 |
| Fenofibrate | 28 | $4,995 | $178 |
| Livalo | 15 | $4,983 | $332 |
| Midodrine | 44 | $4,662 | $106 |
| Lisinopril | 465 | $4,553 | $10 |
| Diovan | 12 | $4,426 | $369 |
| Warfarin | 320 | $4,328 | $14 |
| Isosorbide Mononitrate Er | 159 | $4,168 | $26 |
| Triamterene-Hydrochlorothiazid | 211 | $4,094 | $19 |
| Klor-Con 8 | 103 | $4,037 | $39 |
| Pravastatin | 165 | $3,601 | $22 |
| Fenofibrate | 47 | $3,234 | $69 |
| Cilostazol | 61 | $3,211 | $53 |
| Hydralazine | 102 | $3,164 | $31 |
| Candesartan Cilexetil | 17 | $3,163 | $186 |
| Dilt-Xr | 61 | $3,149 | $52 |
| Amlodipine Besylate-Benazepril | 89 | $3,074 | $35 |
| Propafenone | 36 | $2,987 | $83 |
| Metolazone | 53 | $2,952 | $56 |
| Furosemide | 565 | $2,651 | $5 |
| Flecainide Acetate | 47 | $2,453 | $52 |
| Diltiazem 24hr Cd | 44 | $2,263 | $51 |
| Atenolol | 362 | $2,191 | $6 |
| Toprol Xl | 25 | $2,087 | $83 |
| Cartia Xt | 70 | $2,062 | $29 |
| Valsartan-Hydrochlorothiazide | 44 | $2,040 | $46 |
| Levothyroxine | 66 | $1,586 | $24 |
| Benazepril | 151 | $1,501 | $10 |
| Diltiazem | 72 | $1,468 | $20 |
| Nitrostat | 49 | $1,419 | $29 |
| Klor-Con 10 | 37 | $1,363 | $37 |
| Pantoprazole | 106 | $1,333 | $13 |
| Losartan-Hydrochlorothiazide | 124 | $1,313 | $11 |
| Omeprazole | 95 | $1,296 | $14 |
| Pacerone | 11 | $1,245 | $113 |
| Ranitidine | 61 | $1,240 | $20 |
| Verapamil | 13 | $1,198 | $92 |
| Diltiazem 12hr Er | 14 | $1,007 | $72 |
| Metoprolol | 150 | $998 | $7 |
| Spironolactone | 69 | $969 | $14 |
| Verapamil Er | 20 | $848 | $42 |
| Clonidine | 85 | $827 | $10 |
| Simvastatin | 96 | $756 | $8 |
| Fludrocortisone Acetate | 19 | $719 | $38 |
| Sotalol | 28 | $689 | $25 |
| Digox | 21 | $685 | $33 |
| Nifedipine Er | 20 | $669 | $33 |
| Klor-Con Sprinkle | 12 | $492 | $41 |
| Nitroglycerin | 18 | $460 | $26 |
| Meclizine | 20 | $441 | $22 |
| Isosorbide Dinitrate | 14 | $396 | $28 |
| Bumetanide | 18 | $387 | $21 |
| Cholestyramine | 11 | $359 | $33 |
| Hydrochlorothiazide | 83 | $351 | $4 |
| Lisinopril-Hydrochlorothiazide | 48 | $344 | $7 |
| Propranolol | 16 | $301 | $19 |
| Lovastatin | 15 | $239 | $16 |
| Fosinopril | 14 | $233 | $17 |
| Ropinirole | 17 | $189 | $11 |
| Ramipril | 15 | $148 | $10 |
| Minoxidil | 13 | $135 | $10 |
| Cephalexin | 29 | $94 | $3 |
2015: 98 drugs
| Letairis | 58 | $431,610 | $7,442 |
| Eliquis | 186 | $84,274 | $453 |
| Crestor | 187 | $64,811 | $347 |
| Xarelto | 131 | $63,995 | $489 |
| Zetia | 156 | $55,867 | $358 |
| Metoprolol | 1,140 | $39,152 | $34 |
| Pradaxa | 59 | $36,767 | $623 |
| Sildenafil | 37 | $31,184 | $843 |
| Niacin Er | 121 | $28,431 | $235 |
| Brilinta | 77 | $27,681 | $359 |
| Ranexa | 45 | $26,856 | $597 |
| Atorvastatin | 1,167 | $23,514 | $20 |
| Potassium Chloride | 495 | $21,485 | $43 |
| Welchol | 19 | $18,874 | $993 |
| Benicar | 46 | $14,208 | $309 |
| Diovan | 41 | $13,809 | $337 |
| Valsartan | 94 | $13,615 | $145 |
| Coreg Cr | 32 | $13,082 | $409 |
| Amiodarone | 404 | $11,765 | $29 |
| Bystolic | 67 | $11,695 | $175 |
| Effient | 27 | $10,448 | $387 |
| Clopidogrel | 551 | $9,642 | $17 |
| Fenofibrate | 55 | $9,579 | $174 |
| Losartan | 825 | $9,337 | $11 |
| Midodrine | 75 | $9,197 | $123 |
| Omega-3 Acid Ethyl Esters | 48 | $8,778 | $183 |
| Amlodipine Besylate | 1,183 | $8,212 | $7 |
| Carvedilol | 885 | $7,910 | $9 |
| Candesartan Cilexetil | 26 | $6,673 | $257 |
| Livalo | 28 | $6,406 | $229 |
| Nexium | 24 | $6,068 | $253 |
| Pravastatin | 202 | $5,891 | $29 |
| Fenofibric Acid | 34 | $5,802 | $171 |
| Warfarin | 392 | $5,706 | $15 |
| Isosorbide Mononitrate Er | 177 | $5,553 | $31 |
| Diltiazem 24hr Er | 94 | $5,363 | $57 |
| Lisinopril | 594 | $4,800 | $8 |
| Fenofibrate | 81 | $4,701 | $58 |
| Hydralazine | 169 | $4,379 | $26 |
| Klor-Con 8 | 98 | $4,366 | $45 |
| Diltiazem Er | 100 | $4,317 | $43 |
| Metolazone | 78 | $4,198 | $54 |
| Propafenone | 54 | $4,154 | $77 |
| Cilostazol | 138 | $3,765 | $27 |
| Triamterene-Hydrochlorothiazid | 283 | $3,685 | $13 |
| Exforge | 14 | $3,559 | $254 |
| Amlodipine Besylate-Benazepril | 117 | $3,210 | $27 |
| Cartia Xt | 92 | $3,070 | $33 |
| Atenolol | 508 | $3,032 | $6 |
| Telmisartan | 12 | $3,014 | $251 |
| Furosemide | 669 | $3,002 | $4 |
| Flecainide Acetate | 44 | $2,848 | $65 |
| Omeprazole | 140 | $2,504 | $18 |
| Benazepril | 246 | $2,440 | $10 |
| Coumadin | 24 | $2,412 | $100 |
| Diltiazem 24hr Cd | 62 | $2,158 | $35 |
| Toprol Xl | 29 | $1,894 | $65 |
| Dilt-Xr | 49 | $1,752 | $36 |
| Diltiazem | 121 | $1,661 | $14 |
| Levothyroxine | 73 | $1,584 | $22 |
| Valsartan-Hydrochlorothiazide | 35 | $1,403 | $40 |
| Pantoprazole | 107 | $1,293 | $12 |
| Nitrostat | 65 | $1,281 | $20 |
| Losartan-Hydrochlorothiazide | 98 | $1,268 | $13 |
| Fludrocortisone Acetate | 34 | $1,205 | $35 |
| Simvastatin | 132 | $1,069 | $8 |
| Clonidine | 132 | $1,044 | $8 |
| Metoprolol | 131 | $1,011 | $8 |
| Nifedipine Er | 24 | $938 | $39 |
| Digox | 18 | $848 | $47 |
| Cholestyramine | 13 | $826 | $64 |
| Klor-Con 10 | 23 | $763 | $33 |
| Hydrochlorothiazide | 128 | $703 | $5 |
| Spironolactone | 89 | $703 | $8 |
| Diltiazem 12hr Er | 11 | $688 | $63 |
| Bumetanide | 17 | $685 | $40 |
| Meclizine | 36 | $646 | $18 |
| Lovastatin | 46 | $637 | $14 |
| Digoxin | 12 | $594 | $50 |
| Felodipine Er | 11 | $593 | $54 |
| Fosinopril | 21 | $562 | $27 |
| Ranitidine | 37 | $559 | $15 |
| Klor-Con M20 | 15 | $484 | $32 |
| Sotalol | 18 | $476 | $26 |
| Lisinopril-Hydrochlorothiazide | 49 | $411 | $8 |
| Isosorbide Dinitrate | 13 | $399 | $31 |
| Terazosin | 19 | $384 | $20 |
| Allopurinol | 19 | $348 | $18 |
| Nifedical Xl | 17 | $348 | $20 |
| Verapamil Er | 20 | $287 | $14 |
| Ropinirole | 22 | $245 | $11 |
| Tamsulosin | 12 | $239 | $20 |
| Propranolol | 13 | $178 | $14 |
| Gabapentin | 21 | $153 | $7 |
| Ramipril | 19 | $124 | $7 |
| Minoxidil | 14 | $108 | $8 |
| Prednisone | 19 | $89 | $5 |
| Cephalexin | 21 | $83 | $4 |
2014: 97 drugs
| Letairis | 40 | $284,038 | $7,101 |
| Xarelto | 155 | $64,228 | $414 |
| Crestor | 189 | $62,374 | $330 |
| Metoprolol | 1,128 | $44,011 | $39 |
| Pradaxa | 90 | $40,478 | $450 |
| Niacin Er | 126 | $38,811 | $308 |
| Zetia | 140 | $37,585 | $268 |
| Diovan | 109 | $30,781 | $282 |
| Atorvastatin | 1,180 | $28,103 | $24 |
| Eliquis | 50 | $26,039 | $521 |
| Ranexa | 37 | $19,994 | $540 |
| Welchol | 34 | $19,818 | $583 |
| Benicar | 50 | $14,571 | $291 |
| Clopidogrel | 582 | $13,072 | $22 |
| Potassium Chloride | 287 | $12,959 | $45 |
| Klor-Con 8 | 332 | $12,766 | $38 |
| Carvedilol | 1,083 | $12,744 | $12 |
| Bystolic | 76 | $12,196 | $160 |
| Losartan | 820 | $11,885 | $14 |
| Amlodipine Besylate | 1,316 | $11,132 | $8 |
| Fenofibrate | 58 | $10,195 | $176 |
| Coreg Cr | 29 | $9,157 | $316 |
| Propafenone Hcl Er | 14 | $8,613 | $615 |
| Effient | 25 | $8,455 | $338 |
| Fenofibrate | 113 | $7,874 | $70 |
| Candesartan Cilexetil | 54 | $7,705 | $143 |
| Nexium | 31 | $7,555 | $244 |
| Amlodipine Besylate-Benazepril | 129 | $7,522 | $58 |
| Isosorbide Mononitrate Er | 248 | $7,372 | $30 |
| Brilinta | 23 | $7,198 | $313 |
| Diltiazem 24hr Er | 157 | $6,736 | $43 |
| Pravastatin | 198 | $6,060 | $31 |
| Lisinopril | 715 | $5,924 | $8 |
| Amiodarone | 354 | $5,689 | $16 |
| Warfarin | 462 | $5,502 | $12 |
| Fenofibric Acid | 32 | $5,272 | $165 |
| Valsartan | 21 | $5,255 | $250 |
| Livalo | 25 | $4,830 | $193 |
| Exforge | 16 | $4,643 | $290 |
| Atenolol | 703 | $4,408 | $6 |
| Propafenone | 82 | $4,310 | $53 |
| Cilostazol | 165 | $4,040 | $24 |
| Hydralazine | 149 | $3,994 | $27 |
| Metolazone | 104 | $3,990 | $38 |
| Omega-3 Acid Ethyl Esters | 21 | $3,845 | $183 |
| Benicar Hct | 12 | $3,751 | $313 |
| Coumadin | 34 | $3,707 | $109 |
| Triamterene-Hydrochlorothiazid | 229 | $3,627 | $16 |
| Lovaza | 20 | $3,415 | $171 |
| Midodrine | 34 | $3,409 | $100 |
| Omeprazole | 157 | $3,379 | $22 |
| Furosemide | 702 | $3,354 | $5 |
| Benazepril | 281 | $3,260 | $12 |
| Diltiazem 24hr Cd | 79 | $3,137 | $40 |
| Valsartan-Hydrochlorothiazide | 49 | $3,100 | $63 |
| Diltiazem Er | 76 | $2,913 | $38 |
| Dexilant | 12 | $2,242 | $187 |
| Edarbi | 13 | $2,071 | $159 |
| Klor-Con 10 | 78 | $2,045 | $26 |
| Simvastatin | 204 | $2,039 | $10 |
| Flecainide Acetate | 45 | $1,992 | $44 |
| Toprol Xl | 27 | $1,817 | $67 |
| Losartan-Hydrochlorothiazide | 100 | $1,718 | $17 |
| Nitrostat | 87 | $1,694 | $19 |
| Pantoprazole | 102 | $1,617 | $16 |
| Cartia Xt | 53 | $1,613 | $30 |
| Levothyroxine | 84 | $1,363 | $16 |
| Metoprolol | 164 | $1,310 | $8 |
| Diltiazem | 105 | $1,278 | $12 |
| Meclizine | 59 | $1,258 | $21 |
| Felodipine Er | 11 | $1,225 | $111 |
| Sotalol | 28 | $1,207 | $43 |
| Nifedipine Er | 22 | $1,166 | $53 |
| Digox | 17 | $1,140 | $67 |
| Spironolactone | 110 | $1,018 | $9 |
| Clonidine | 147 | $997 | $7 |
| Fludrocortisone Acetate | 29 | $945 | $33 |
| Benazepril-Hydrochlorothiazide | 13 | $737 | $57 |
| Lisinopril-Hydrochlorothiazide | 83 | $717 | $9 |
| Fosinopril | 25 | $717 | $29 |
| Hydrochlorothiazide | 118 | $709 | $6 |
| Bumetanide | 18 | $696 | $39 |
| Digoxin | 15 | $693 | $46 |
| Lovastatin | 43 | $686 | $16 |
| Klor-Con M20 | 26 | $667 | $26 |
| Ranitidine | 34 | $541 | $16 |
| Ramipril | 20 | $411 | $21 |
| Nifedical Xl | 16 | $377 | $24 |
| Verapamil Er | 12 | $332 | $28 |
| Gabapentin | 22 | $273 | $12 |
| Ropinirole | 14 | $211 | $15 |
| Allopurinol | 14 | $182 | $13 |
| Pacerone | 15 | $137 | $9 |
| Minoxidil | 12 | $78 | $7 |
| Cephalexin | 18 | $64 | $4 |
| Estradiol | 11 | $48 | $4 |
| Enalapril Maleate | 11 | $0 | $0 |
2013: 101 drugs
| Tracleer | 15 | $100,985 | $6,732 |
| Letairis | 12 | $79,014 | $6,585 |
| Crestor | 257 | $68,306 | $266 |
| Metoprolol | 1,310 | $52,854 | $40 |
| Pradaxa | 104 | $44,831 | $431 |
| Diovan | 182 | $42,985 | $236 |
| Niaspan | 113 | $38,522 | $341 |
| Zetia | 165 | $36,780 | $223 |
| Xarelto | 95 | $32,058 | $337 |
| Atorvastatin | 926 | $31,866 | $34 |
| Clopidogrel | 581 | $28,136 | $48 |
| Propafenone | 101 | $22,219 | $220 |
| Klor-Con 8 | 500 | $18,312 | $37 |
| Benicar | 64 | $17,024 | $266 |
| Amlodipine Besylate-Benazepril | 210 | $15,380 | $73 |
| Multaq | 28 | $14,977 | $535 |
| Carvedilol | 1,130 | $14,258 | $13 |
| Losartan | 753 | $14,177 | $19 |
| Ranexa | 38 | $13,442 | $354 |
| Amlodipine Besylate | 1,297 | $12,365 | $10 |
| Welchol | 21 | $11,465 | $546 |
| Bystolic | 73 | $11,150 | $153 |
| Fenofibrate | 140 | $10,218 | $73 |
| Valsartan-Hydrochlorothiazide | 83 | $9,942 | $120 |
| Fenofibrate | 56 | $9,938 | $177 |
| Diltiazem 24hr Cd | 107 | $8,434 | $79 |
| Lisinopril | 890 | $8,001 | $9 |
| Isosorbide Mononitrate Er | 273 | $7,553 | $28 |
| Coreg Cr | 29 | $6,844 | $236 |
| Warfarin | 594 | $6,841 | $12 |
| Potassium Chloride | 190 | $6,588 | $35 |
| Niacin Er | 22 | $6,179 | $281 |
| Lovaza | 24 | $6,148 | $256 |
| Vytorin | 14 | $6,021 | $430 |
| Amiodarone | 401 | $5,961 | $15 |
| Trilipix | 23 | $5,777 | $251 |
| Atenolol | 860 | $5,647 | $7 |
| Diltiazem 24hr Er | 160 | $5,280 | $33 |
| Exforge | 19 | $5,090 | $268 |
| Livalo | 30 | $5,067 | $169 |
| Cilostazol | 125 | $4,830 | $39 |
| Effient | 12 | $4,732 | $394 |
| Diltiazem Er | 105 | $4,351 | $41 |
| Pravastatin | 253 | $4,212 | $17 |
| Omeprazole | 179 | $4,127 | $23 |
| Furosemide | 798 | $4,048 | $5 |
| Nexium | 13 | $3,985 | $307 |
| Fenofibric Acid | 18 | $3,859 | $214 |
| Hydralazine | 145 | $3,780 | $26 |
| Benicar Hct | 13 | $3,713 | $286 |
| Nisoldipine | 12 | $3,616 | $301 |
| Simvastatin | 327 | $3,569 | $11 |
| Klor-Con 10 | 88 | $3,550 | $40 |
| Benazepril | 329 | $3,548 | $11 |
| Micardis | 16 | $3,467 | $217 |
| Coumadin | 32 | $2,850 | $89 |
| Losartan-Hydrochlorothiazide | 104 | $2,482 | $24 |
| Midodrine | 17 | $2,428 | $143 |
| Metolazone | 105 | $2,378 | $23 |
| Toprol Xl | 29 | $2,356 | $81 |
| Flecainide Acetate | 33 | $2,286 | $69 |
| Pantoprazole | 88 | $2,214 | $25 |
| Triamterene-Hydrochlorothiazid | 117 | $2,192 | $19 |
| Fludrocortisone Acetate | 41 | $1,744 | $43 |
| Nitrostat | 111 | $1,539 | $14 |
| Atacand | 12 | $1,471 | $123 |
| Metoprolol | 161 | $1,412 | $9 |
| Cartia Xt | 38 | $1,346 | $35 |
| Nifedipine Er | 26 | $1,335 | $51 |
| Felodipine Er | 18 | $1,300 | $72 |
| Lisinopril-Hydrochlorothiazide | 129 | $1,180 | $9 |
| Levothyroxine | 127 | $1,151 | $9 |
| Clonidine | 141 | $1,147 | $8 |
| Verapamil Er | 33 | $1,134 | $34 |
| Lovastatin | 72 | $1,126 | $16 |
| Spironolactone | 99 | $976 | $10 |
| Diltiazem | 89 | $888 | $10 |
| Ropinirole | 36 | $865 | $24 |
| Sotalol | 18 | $860 | $48 |
| Benazepril-Hydrochlorothiazide | 25 | $737 | $29 |
| Hydrochlorothiazide | 96 | $690 | $7 |
| Meclizine | 42 | $617 | $15 |
| Taztia Xt | 11 | $502 | $46 |
| Ranitidine | 44 | $470 | $11 |
| Fosinopril | 17 | $452 | $27 |
| Gabapentin | 31 | $444 | $14 |
| Ramipril | 21 | $438 | $21 |
| Klor-Con M20 | 23 | $419 | $18 |
| Sotalol Af | 14 | $393 | $28 |
| Triamterene-Hctz | 41 | $344 | $8 |
| Pacerone | 27 | $321 | $12 |
| Bumetanide | 26 | $313 | $12 |
| Hydrocodone-Acetaminophen | 12 | $245 | $20 |
| Digox | 27 | $232 | $9 |
| Isosorbide Mononitrate | 13 | $227 | $17 |
| Minoxidil | 13 | $177 | $14 |
| Verapamil | 25 | $174 | $7 |
| Prednisone | 22 | $112 | $5 |
| Cephalexin | 21 | $87 | $4 |
| Zolpidem | 16 | $86 | $5 |
| Folic Acid | 11 | $55 | $5 |
Money from drug and device companies
$4,298 in 2025
| 2025 | 17 | 100 | None | $4,298 |
| 2024 | 27 | 115 | None | $5,359 |
| 2023 | 23 | 102 | $6,600 | $11,376 |
| 2022 | 22 | 75 | None | $3,205 |
| 2021 | 20 | 89 | None | $2,999 |
| 2020 | 17 | 97 | None | $4,752 |
| 2019 | 27 | 209 | $500 | $18,021 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abiomed | None | $1,446 | 11 payments
|
| Abbott Laboratories | Navitor | $514 | 9 payments
|
| Philips North America | Igt Devices Undivided | $406 | 5 payments
|
| Shockwave Medical | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $391 | 3 payments
|
| Amgen | Repatha | $316 | 25 payments
|
| Novartis Pharmaceuticals | Leqvio | $275 | 24 payments
|
See all 100 published payments
| Amgen | Meals · 2025-12-19 | Repatha | $8 |
| Pfizer | Meals · 2025-12-16 | Eliquis | $16 |
| Amgen | Meals · 2025-12-11 | Repatha | $7 |
| Medtronic | Meals · 2025-12-05 | Azure Xt Dr Mri Surescan | $50 |
| Shockwave Medical | Meals · 2025-12-02 | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $143 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-11-26 | Kerendia | $20 |
| Amgen | Meals · 2025-11-25 | Repatha | $6 |
| Abiomed | Meals · 2025-11-21 | None | $144 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-11-14 | Jardiance | $14 |
| Medtronic | Meals · 2025-11-06 | Azure Xt Dr Mri Surescan | $21 |
| Amgen | Meals · 2025-11-06 | Repatha | $14 |
| Amgen | Meals · 2025-10-28 | Repatha | $7 |
| Philips North America | Meals · 2025-10-24 | Igt Devices Undivided | $61 |
| Abiomed | Travel · 2025-10-22 | None | $470 |
| Philips North America | Meals · 2025-10-22 | Igt Devices Undivided | $43 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-10-21 | Lifevest | $10 |
| Abiomed | Meals · 2025-10-18 | None | $40 |
| Abiomed | Meals · 2025-10-18 | None | $70 |
| Abiomed | Meals · 2025-10-18 | None | $50 |
| Abiomed | Meals · 2025-10-17 | None | $150 |
| Philips North America | Travel · 2025-10-17 | Igt Devices Undivided | $3 |
| Philips North America | Travel · 2025-10-17 | Igt Devices Undivided | $269 |
| Amgen | Meals · 2025-10-15 | Repatha | $125 |
| Amgen | Meals · 2025-10-14 | Repatha | $8 |
| Amgen | Meals · 2025-10-09 | Repatha | $8 |
| Abbott Laboratories | Meals · 2025-10-09 | Jot Dx | $66 |
| Abbott Laboratories | Meals · 2025-10-08 | Navitor | $175 |
| United Therapeutics | Meals · 2025-09-25 | None | $77 |
| Amgen | Meals · 2025-09-24 | Repatha | $7 |
| Abbott Laboratories | Meals · 2025-09-24 | Aveir | $15 |
| Novartis Pharmaceuticals | Meals · 2025-09-23 | Leqvio | $26 |
| Novartis Pharmaceuticals | Meals · 2025-09-12 | Leqvio | $19 |
| Novartis Pharmaceuticals | Meals · 2025-09-12 | Leqvio | $3 |
| Novartis Pharmaceuticals | Meals · 2025-09-05 | Leqvio | $9 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-09-05 | Kerendia | $18 |
| Novartis Pharmaceuticals | Meals · 2025-08-26 | Leqvio | $10 |
| Novartis Pharmaceuticals | Meals · 2025-08-20 | Leqvio | $9 |
| Amgen | Meals · 2025-08-15 | Repatha | $15 |
| Novartis Pharmaceuticals | Meals · 2025-08-14 | Leqvio | $5 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-08-14 | Kerendia | $25 |
| Amgen | Meals · 2025-08-13 | Repatha | $5 |
| Abiomed | Meals · 2025-08-12 | None | $124 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-08-11 | Camzyos | $122 |
| Novartis Pharmaceuticals | Meals · 2025-07-30 | Leqvio | $5 |
| Abiomed | Meals · 2025-07-29 | None | $101 |
| Amgen | Meals · 2025-07-24 | Repatha | $8 |
| Abbott Laboratories | Meals · 2025-07-21 | Merlin@Home | $11 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-07-09 | Lifevest | $17 |
| Amgen | Meals · 2025-07-09 | Repatha | $8 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-07-02 | Kerendia | $29 |
| Amgen | Meals · 2025-06-25 | Repatha | $18 |
| Abiomed | Meals · 2025-06-23 | None | $104 |
| Boston Scientific | Meals · 2025-06-17 | General - Balloon Catheters | $104 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-06-14 | Adempas | $122 |
| Amgen | Meals · 2025-06-12 | Repatha | $6 |
| Actelion Pharmaceuticals US | Meals · 2025-06-11 | Opsumit | $40 |
| Abbott Laboratories | Meals · 2025-06-06 | Eterna | $24 |
| Amgen | Meals · 2025-06-05 | Repatha | $6 |
| Novartis Pharmaceuticals | Meals · 2025-06-04 | Leqvio | $25 |
| Novartis Pharmaceuticals | Meals · 2025-06-04 | Leqvio | $4 |
| Amgen | Meals · 2025-06-04 | Repatha | $11 |
| Amgen | Meals · 2025-05-23 | Repatha | $8 |
| Shockwave Medical | Meals · 2025-05-21 | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $123 |
| Novartis Pharmaceuticals | Meals · 2025-05-20 | Leqvio | $10 |
| Scpharmaceuticals | Meals · 2025-05-14 | Furoscix | $23 |
| Amgen | Meals · 2025-05-13 | Repatha | $6 |
| Abbott Laboratories | Meals · 2025-05-08 | Merlin@Home | $31 |
| Abbott Laboratories | Meals · 2025-05-08 | Gallant | $29 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-04-30 | Kerendia | $17 |
| Novartis Pharmaceuticals | Meals · 2025-04-28 | Leqvio | $22 |
| Novartis Pharmaceuticals | Meals · 2025-04-28 | Leqvio | $3 |
| Medtronic | Meals · 2025-04-28 | Corevalve Evolut R | $116 |
| Novartis Pharmaceuticals | Meals · 2025-04-25 | Leqvio | $8 |
| Abiomed | Meals · 2025-04-24 | None | $49 |
| Shockwave Medical | Meals · 2025-04-23 | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $125 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-04-16 | Adempas | $25 |
| Novartis Pharmaceuticals | Meals · 2025-04-09 | Leqvio | $25 |
| Novartis Pharmaceuticals | Meals · 2025-04-09 | Leqvio | $3 |
| Amgen | Meals · 2025-04-03 | Repatha | $6 |
| AtriCure | Meals · 2025-04-02 | Atriclip Laa Exclusion System | $27 |
| Abbott Laboratories | Meals · 2025-03-31 | Gallant | $55 |
| Boston Scientific | Meals · 2025-03-29 | Farapulse | $26 |
| Novartis Pharmaceuticals | Meals · 2025-03-27 | Leqvio | $5 |
| Medtronic | Meals · 2025-03-25 | Azure Xt Dr Mri Surescan | $21 |
| Amgen | Meals · 2025-03-19 | Repatha | $6 |
| Philips North America | Meals · 2025-03-17 | Igt Devices Systems Undivided | $29 |
| Abiomed | Meals · 2025-03-12 | None | $144 |
| Novartis Pharmaceuticals | Meals · 2025-03-10 | Leqvio | $12 |
| Novartis Pharmaceuticals | Meals · 2025-03-05 | Leqvio | $23 |
| Amgen | Meals · 2025-03-04 | Repatha | $7 |
| Amgen | Meals · 2025-02-20 | Repatha | $6 |
| Novartis Pharmaceuticals | Meals · 2025-02-18 | Leqvio | $11 |
| Novartis Pharmaceuticals | Meals · 2025-02-13 | Leqvio | $5 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-02-04 | Lifevest | $11 |
| Amgen | Meals · 2025-01-28 | Repatha | $7 |
| Novartis Pharmaceuticals | Meals · 2025-01-27 | Leqvio | $10 |
| Abbott Laboratories | Meals · 2025-01-10 | Aveir | $108 |
| Novartis Pharmaceuticals | Meals · 2025-01-08 | Leqvio | $19 |
| Novartis Pharmaceuticals | Meals · 2025-01-07 | Leqvio | $5 |
| Amgen | Meals · 2025-01-07 | Repatha | $5 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $5,359
| Penumbra | Indigo System | $1,147 | 5 payments
|
| Amgen | Repatha | $656 | 23 payments
|
| Medtronic | Corevalve Evolut R | $427 | 8 payments
|
| ShockWave Medical | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $385 | 4 payments
|
| Abiomed | Impella | $324 | 6 payments
|
| Boston Scientific | Emerge Push | $242 | 3 payments
|
| Novo Nordisk | Wegovy | $242 | 2 payments
|
| Abbott Laboratories | Jot Dx | $234 | 5 payments
|
| Bayer Healthcare Pharmaceuticals | Adempas | $223 | 8 payments
|
| Novartis Pharmaceuticals | Leqvio | $218 | 14 payments
|
| Biotronik | Amvia Edge | $216 | 2 payments
|
| Merck Sharp & Dohme | Winrevair | $199 | 4 payments
|
| Esperion Therapeutics | Nexlizet | $150 | 3 payments
|
| Lexicon Pharmaceuticals | Inpefa | $125 | 1 payment
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $105 | 5 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $92 | 5 payments
|
| Scpharmaceuticals | Furoscix | $64 | 3 payments
|
| Cordis US | Mynx Venous Vcd | $46 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $44 | 2 payments
|
| Actelion Pharmaceuticals US | Opsumit | $43 | 2 payments
|
| CVRx | Barostim Neo System | $43 | 2 payments
|
| iRhythm Technologies | Zio Monitor | $25 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Andexxa | $25 | 1 payment
|
| Cardiva Medical | Savvywire | $23 | 1 payment
|
| Becton Dickinson and | Arista Ah Flexitip | $21 | 1 payment
|
| Kiniksa Pharmaceuticals International plc | Arcalyst | $21 | 1 payment
|
| Daiichi Sankyo | Injectafer | $17 | 1 payment
|
2023: $11,376
| ShockWave Medical | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $7,379 | 6 payments
|
| Abbott Laboratories | Mitraclip | $546 | 9 payments
|
| Amgen | Repatha | $539 | 16 payments
|
| Abiomed | Impella | $418 | 5 payments
|
| Bayer Healthcare Pharmaceuticals | Adempas | $405 | 10 payments
|
| E.R. Squibb & Sons L.L.C. | Camzyos | $364 | 9 payments
|
| Medtronic | Azure Xt Dr Mri Surescan | $347 | 9 payments
|
| CVRx | Barostim Neo System | $305 | 6 payments
|
| Boston Scientific | Opticross | $197 | 2 payments
|
| Edwards Lifesciences | Edwards Sapien 3 Transcatheter Heart Valve (Thv) | $152 | 2 payments
|
| Actelion Pharmaceuticals US | Uptravi | $144 | 3 payments
|
| Esperion Therapeutics | Nexlizet | $138 | 3 payments
|
| Merck Sharp & Dohme | Verquvo | $92 | 4 payments
|
| Novartis Pharmaceuticals | Entresto | $55 | 2 payments
|
| Kiniksa Pharmaceuticals | Arcalyst | $49 | 2 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $48 | 4 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $45 | 2 payments
|
| Scpharmaceuticals | Furoscix | $39 | 2 payments
|
| Novo Nordisk | None | $32 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Andexxa | $25 | 1 payment
|
| Lilly USA | Mounjaro | $20 | 1 payment
|
| AngioDynamics | Alphavac | $19 | 1 payment
|
| Inspire Medical Systems | Inspire | $18 | 1 payment
|
2022: $3,205
| Abiomed | Impella | $636 | 9 payments
|
| Amgen | Repatha | $439 | 11 payments
|
| Boston Scientific | Emblem Mri S-Icd | $412 | 4 payments
|
| Bayer HealthCare Pharmaceuticals | Kerendia | $233 | 8 payments
|
| Shockwave Medical | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $232 | 2 payments
|
| Medtronic | Avalus | $213 | 5 payments
|
| Novartis Pharmaceuticals | Entresto | $152 | 11 payments
|
| Biotronik | Biomonitor | $148 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $125 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $125 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $96 | 5 payments
|
| Actelion Pharmaceuticals US | Opsumit | $63 | 2 payments
|
| Abbott Laboratories | Durata | $60 | 1 payment
|
| Kiniksa Pharmaceuticals | Arcalyst | $57 | 3 payments
|
| Amarin Pharma | Vascepa | $46 | 2 payments
|
| Merck Sharp & Dohme | Verquvo | $39 | 2 payments
|
| Esperion Therapeutics | Nexletol | $38 | 2 payments
|
| Bracco Diagnostics | Cardiogen-82 | $23 | 1 payment
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $20 | 1 payment
|
| Pfizer | Eliquis | $18 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Andexxa | $16 | 1 payment
|
| Tactile Systems Technology | Flexitouch Plus | $14 | 1 payment
|
2021: $2,999
| Medtronic | 3f | $488 | 8 payments
|
| Boston Scientific | Lux Dx | $365 | 5 payments
|
| Amgen | Repatha | $316 | 17 payments
|
| Edwards Lifesciences | None | $272 | 3 payments
|
| Abiomed | Impella | $261 | 4 payments
|
| Abbott Laboratories | Confirm Rx | $243 | 7 payments
|
| Penumbra | Indigo System | $154 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $149 | 3 payments
|
| Bayer HealthCare Pharmaceuticals | Adempas | $145 | 10 payments
|
| Amarin Pharma | Vascepa | $143 | 12 payments
|
| Novartis Pharmaceuticals | Entresto | $109 | 5 payments
|
| Shockwave Medical | Vascular Lithotripsy | $79 | 1 payment
|
| Esperion Therapeutics | Nexletol | $70 | 4 payments
|
| Biotronik | Edora | $56 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $45 | 3 payments
|
| Pfizer | Eliquis | $28 | 1 payment
|
| United Therapeutics | Orenitram | $24 | 1 payment
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $21 | 1 payment
|
| Actelion Pharmaceuticals US | Opsumit | $18 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $13 | 1 payment
|
2020: $4,752
| Medtronic Vascular | Resolute | $2,532 | 14 payments
|
| Amarin Pharma | Vascepa | $583 | 28 payments
|
| Amgen | Corlanor | $290 | 12 payments
|
| Janssen Pharmaceuticals | Xarelto | $277 | 5 payments
|
| Abbott Laboratories | Merlin Connectivity and Remote | $223 | 6 payments
|
| Boston Scientific | Watchman | $210 | 9 payments
|
| Abiomed | Impella | $179 | 5 payments
|
| Shockwave Medical | Vascular Lithotripsy | $99 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $82 | 4 payments
|
| Actelion Pharmaceuticals US | Uptravi | $80 | 3 payments
|
| Boehringer Ingelheim Pharmaceuticals | Pradaxa | $43 | 2 payments
|
| Esperion Therapeutics | Nexletol | $40 | 2 payments
|
| Pfizer | Eliquis | $35 | 2 payments
|
| Akcea Therapeutics | Tegsedi | $22 | 1 payment
|
| Arbor Pharmaceuticals | Edarbi | $20 | 1 payment
|
| Bayer HealthCare Pharmaceuticals | Adempas | $18 | 1 payment
|
| United Therapeutics | None | $17 | 1 payment
|
2019: $18,021
| Medtronic Vascular | Resolute | $11,595 | 38 payments
|
| Abiomed | Impella | $1,381 | 20 payments
|
| Amgen | Repatha | $845 | 28 payments
|
| Boston Scientific | Watchman | $530 | 10 payments
|
| Philips Electronics North America | Spectranetics Undiv | $500 | 1 payment
|
| Novartis Pharmaceuticals | Entresto | $317 | 10 payments
|
| AstraZeneca Pharmaceuticals LP | Brilinta | $258 | 10 payments
|
| Pfizer | Vyndaqel | $240 | 8 payments
|
| Edwards Lifesciences | None | $231 | 2 payments
|
| Amarin Pharma | Vascepa | $210 | 22 payments
|
| Actelion Pharmaceuticals US | Uptravi | $210 | 10 payments
|
| Sanofi-Aventis U.S. | Praluent | $206 | 7 payments
|
| Biotronik | None | $185 | 3 payments
|
| Aziyo Biologics | Ecm Patch,Pouch | $163 | 1 payment
|
| Intuitive Surgical | Da Vinci Surgical System | $161 | 1 payment
|
| Janssen Pharmaceuticals | Invokana | $159 | 6 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $144 | 2 payments
|
| Chiesi USA | Kengreal | $131 | 3 payments
|
| Gilead Sciences | Letairis | $126 | 13 payments
|
| Akcea Therapeutics | Tegsedi | $125 | 1 payment
|
| Abbott Laboratories | Merlin Connectivity and Remote | $120 | 2 payments
|
| Bayer HealthCare Pharmaceuticals | Adempas | $43 | 3 payments
|
| Genzyme | Fabry-Disease | $39 | 2 payments
|
| Lundbeck | Northera | $38 | 2 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $32 | 2 payments
|
| CathWorks | Ffrangio System | $21 | 1 payment
|
| InfoBionic | Mome Kardia | $12 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 81.2 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1982673406
- Licence
- CA G56843California G56843: Current · expires 2027-09-30
- Trained
- University of Pittsburgh School of Medicine, 1977 · 49 years ago
- Group
- Cardiovascular Consultants of Fresno, A Professional Corporation · Saint Agnes Medical Center · Fresno Community Hospital and Medical Center
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RI0011X (207RI0011X); Cardiology (207RC0000X)
- Mailing address
- 1207 E Herndon Ave, Fresno, CA, 93720
- NPI first listed
- 2006-03-16
- NPI last updated
- 2024-03-12
- NPI record certified
- 2024-03-12
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 729 N Medical Center Dr W, Clovis, CA, 93611 · 1193 E Herndon Ave Ste 105, Fresno, CA, 93720